Annotation Detail for NPPA
Basic Information Top
| Gene Symbol: | NPPA ( ANF,ANP,ATFB6,CDD-ANF,PND ) |
|---|---|
| Gene Full Name: | natriuretic peptide precursor A |
| Band: | 1p36.22 |
| Quick Links | Entrez ID:4878; OMIM: 108780; Uniprot ID:ANF_HUMAN; ENSEMBL ID: ENSG00000175206; HGNC ID: 7939 |
| Relate to Another Database: | SFARIGene; denovo-db |
| No data |
| No data |
| No data |
| Pathway ID | Pathway Name |
|---|---|
| 200118 | AP-1 transcription factor network |
| No data |
| No data |
| No data |
| No data |
| Desease Name |
|---|
| HEMATOLOGICAL |
| Atrial Fibrillation |
| atherosclerosis, coronary |
| blood pressure, arterial |
| CARDIOVASCULAR |
| myocardial infarct |
| left ventricular hypertrophy |
| aldosterone responsiveness to angiotensin |
| blood pressure |
| systolic blood pressure |
| Asthma |
| left ventricular mass ventricular remodeling |
| cardiovascular |
| IMMUNE |
| METABOLIC |
| DEVELOPMENTAL |
| Albuminuria |
| limb deficiency anomalies |
| No data |
| Desease Name |
|---|
| Atrial fibrillation, familial, 6 |
| Chemical ID | Chemical Name | Interaction | Interaction Action | Publication |
|---|---|---|---|---|
| C097949 | 1,25-dihydroxyvitamin D | 1,25-dihydroxyvitamin D results in decreased expression of NPPA mRNA | decreases expression | 15837528 |
| C051360 | 1,3-dipropyl-8-cyclopentylxanthine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C051360 | 1,3-dipropyl-8-cyclopentylxanthine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| C120227 | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 12513686 |
| C419146 | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C419146 | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966059 15452191 |
| C061282 | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine | Caffeine analog inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| C109986 | 2-aminoethoxydiphenyl borate | 2-aminoethoxydiphenyl borate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16787574 |
| C109986 | 2-aminoethoxydiphenyl borate | chelerythrine promotes the reaction [2-aminoethoxydiphenyl borate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression|increases reaction | 16787574 |
| C520164 | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15721863 |
| C001789 | 4-nitrobenzylthioinosine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C001789 | 4-nitrobenzylthioinosine | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C001789 | 4-nitrobenzylthioinosine | 8-(3-chlorostyryl)caffeine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C001789 | 4-nitrobenzylthioinosine | 8-(4-sulfophenyl)theophylline inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C001789 | 4-nitrobenzylthioinosine | [9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C033502 | 4-trifluoromethylsalicylic acid | 4-trifluoromethylsalicylic acid inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 16421291 |
| C081320 | 8-(3-chlorostyryl)caffeine | 8-(3-chlorostyryl)caffeine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C055656 | 8-((4-chlorophenyl)thio)cyclic-3',5'-GMP | [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084 |
| C031433 | 8-(4-sulfophenyl)theophylline | 8-(4-sulfophenyl)theophylline inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C010192 | 9-(2-hydroxy-3-nonyl)adenine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C010192 | 9-(2-hydroxy-3-nonyl)adenine | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C010192 | 9-(2-hydroxy-3-nonyl)adenine | 8-(3-chlorostyryl)caffeine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C010192 | 9-(2-hydroxy-3-nonyl)adenine | 8-(4-sulfophenyl)theophylline inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C010192 | 9-(2-hydroxy-3-nonyl)adenine | [9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| C016957 | adenosine-3',5'-cyclic phosphorothioate | adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D000242 | Cyclic AMP | [8-Bromo Cyclic Adenosine Monophosphate results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein | decreases expression|increases abundance | 12714356 |
| D000242 | Cyclic AMP | adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D000242 | Cyclic AMP | Cimetidine inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D000242 | Cyclic AMP | [Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein | decreases expression|increases abundance | 12714356 |
| D000242 | Cyclic AMP | HRH2 protein promotes the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|increases abundance|increases reaction | 12714356 |
| D000242 | Cyclic AMP | KT 5720 inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D000242 | Cyclic AMP | Staurosporine inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D000450 | Aldosterone | Aldosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 19966502 |
| D000450 | Aldosterone | Aldosterone results in increased expression of NPPA mRNA | increases expression | 19966502 |
| D000450 | Aldosterone | Spironolactone inhibits the reaction [Aldosterone results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966502 |
| D000638 | Amiodarone | Amiodarone results in increased expression of NPPA mRNA | increases expression | 17535870 |
| D000643 | Ammonium Chloride | Ammonium Chloride affects the expression of NPPA mRNA | affects expression | 16483693 |
| D001151 | Arsenic | Arsenic results in increased expression of NPPA mRNA | increases expression | 19654921 |
| D001374 | Azacitidine | Azacitidine results in increased expression of NPPA | increases expression | 15005238 |
| D019324 | beta-Naphthoflavone | beta-Naphthoflavone results in increased expression of NPPA mRNA | increases expression | 19969063 |
| D001564 | Benzo(a)pyrene | Benzo(a)pyrene results in increased expression of NPPA mRNA | increases expression | 19889059 |
| D001564 | Benzo(a)pyrene | N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine inhibits the reaction [Benzo(a)pyrene results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19889059 |
| C088060 | bisindolylmaleimide | bisindolylmaleimide inhibits the reaction [MBF1 protein results in increased secretion of NPPA protein] | decreases reaction|increases secretion | 12729799 |
| C086539 | BQ 788 | BQ 788 inhibits the reaction [AGT protein results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15007106 |
| C086539 | BQ 788 | BQ 788 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15007106 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | [8-Bromo Cyclic Adenosine Monophosphate results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein | decreases expression|increases abundance | 12714356 |
| D015124 | 8-Bromo Cyclic Adenosine Monophosphate | KT 5720 inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D002110 | Caffeine | Caffeine analog inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| C060942 | candoxatrilat | candoxatrilat inhibits the reaction [Carbon Tetrachloride results in decreased secretion of NPPA protein] | decreases reaction|decreases secretion | 16449355 |
| C071423 | capsazepine | capsazepine inhibits the reaction [NPPA protein results in increased secretion of CALCA protein] | decreases reaction|increases secretion | 17522345 |
| D002251 | Carbon Tetrachloride | candoxatrilat inhibits the reaction [Carbon Tetrachloride results in decreased secretion of NPPA protein] | decreases reaction|decreases secretion | 16449355 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in decreased secretion of NPPA protein | decreases secretion | 16449355 |
| D002251 | Carbon Tetrachloride | Carbon Tetrachloride results in increased expression of NPPA mRNA | increases expression | 16644059 |
| C511403 | CGS 35601 | CGS 35601 affects the expression of NPPA protein | affects expression | 16364833 |
| C016299 | chelerythrine | chelerythrine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16787574 |
| C016299 | chelerythrine | chelerythrine promotes the reaction [2-aminoethoxydiphenyl borate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression|increases reaction | 16787574 |
| D015762 | 2-Chloroadenosine | 2-Chloroadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15452191 |
| C034587 | CHOP protocol | CHOP protocol results in increased expression of NPPA protein | increases expression | 16247790 |
| D002927 | Cimetidine | Cimetidine inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| C014282 | cirazoline | ADRA1A protein promotes the reaction [cirazoline results in increased expression of NPPA protein] | increases expression|increases reaction | 18378355 |
| C014282 | cirazoline | cirazoline results in increased expression of NPPA protein | increases expression | 18378355 |
| D003000 | Clonidine | Clonidine results in increased expression of NPPA protein | increases expression | 18378355 |
| C018021 | cobaltous chloride | cobaltous chloride results in increased expression of NPPA mRNA | increases expression | 11078377 |
| D003345 | Corticosterone | Corticosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 16533503 |
| D003345 | Corticosterone | Corticosterone results in increased expression of NPPA mRNA | increases expression | 16533503 |
| D003484 | Cyanamide | [Ethanol co-treated with Cyanamide] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 10905996 |
| D016572 | Cyclosporine | Cyclosporine affects the expression of NPPA mRNA | affects expression | 19244478 |
| D016572 | Cyclosporine | Cyclosporine inhibits the reaction [IGF1 protein results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11548882 |
| C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [AGT protein results in increased expression of NPPA protein] | decreases reaction|increases expression | 15007106 |
| C072247 | cyclo(Trp-Asp-Pro-Val-Leu) | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15007106 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [nitrofen results in decreased expression of NPPA mRNA] | decreases expression|decreases reaction | 11584395 |
| D003907 | Dexamethasone | Dexamethasone inhibits the reaction [nitrofen results in decreased expression of NPPA protein] | decreases expression|decreases reaction | 11584395 |
| D019259 | Lamivudine | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 11706060 |
| D019422 | Dietary Sucrose | Dietary Sucrose promotes the reaction [Sodium, Dietary results in increased expression of NPPA mRNA] | increases expression|increases reaction | 18551017 |
| D004054 | Diethylstilbestrol | Diethylstilbestrol results in increased expression of NPPA protein | increases expression | 15283993 |
| D004317 | Doxorubicin | Doxorubicin results in decreased expression of NPPA mRNA | decreases expression | 17531194 |
| D004317 | Doxorubicin | Fenofibrate inhibits the reaction [Doxorubicin results in decreased expression of NPPA mRNA] | decreases expression|decreases reaction | 17531194 |
| D004317 | Doxorubicin | Doxorubicin results in increased expression of NPPA mRNA | increases expression | 16766856 |
| D004958 | Estradiol | Estradiol results in increased expression of NPPA protein | increases expression | 14718400 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [[Estradiol co-treated with Phenylephrine] results in increased expression of NPPA protein] | affects cotreatment|decreases reaction|increases expression | 14718400 |
| D004958 | Estradiol | fulvestrant inhibits the reaction [Estradiol results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 14718400 |
| D000431 | Ethanol | [Ethanol co-treated with Cyanamide] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 10905996 |
| D000431 | Ethanol | Ethanol results in increased expression of NPPA mRNA | increases expression | 11181050 |
| D011345 | Fenofibrate | Fenofibrate inhibits the reaction [Doxorubicin results in decreased expression of NPPA mRNA] | decreases expression|decreases reaction | 17531194 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Dinoprostone results in increased expression of NPPA protein] | decreases reaction|increases expression | 18851973 |
| D005576 | Forskolin | Forskolin inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11470465 18851973 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [[Estradiol co-treated with Phenylephrine] results in increased expression of NPPA protein] | affects cotreatment|decreases reaction|increases expression | 14718400 |
| C070081 | fulvestrant | fulvestrant inhibits the reaction [Estradiol results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 14718400 |
| D005839 | Gentamicins | Gentamicins results in increased expression of NPPA mRNA | increases expression | 17312373 |
| D005947 | Glucose | NPPA protein inhibits the reaction [SLC5A2 protein results in increased uptake of Glucose] | decreases reaction|increases uptake | 15127950 |
| D006143 | Guanabenz | Guanabenz results in increased expression of NPPA protein | increases expression | 18378355 |
| D006152 | Cyclic GMP | Cyclic GMP affects the reaction [NPPA protein alternative form results in decreased phosphorylation of and results in decreased activity of MAP2K1 protein] | affects reaction|decreases activity|decreases phosphorylation | 18225537 |
| D006152 | Cyclic GMP | Cyclic GMP affects the reaction [NPPA protein alternative form results in decreased phosphorylation of and results in decreased activity of MAP2K2 protein] | affects reaction|decreases activity|decreases phosphorylation | 18225537 |
| D006152 | Cyclic GMP | AGT protein inhibits the reaction [NPPA protein results in increased abundance of Cyclic GMP] | decreases reaction|increases abundance | 11696475 |
| D006152 | Cyclic GMP | NPPA protein results in increased abundance of Cyclic GMP | increases abundance | 12022755 11696475 |
| D006152 | Cyclic GMP | vinpocetine inhibits the reaction [AGT protein inhibits the reaction [NPPA protein results in increased abundance of Cyclic GMP]] | decreases reaction|increases abundance | 11696475 |
| C425931 | GW 501516 | [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects binding|decreases reaction|increases expression | 18701451 |
| D006632 | Histamine | adenosine-3',5'-cyclic phosphorothioate inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D006632 | Histamine | Cimetidine inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D006632 | Histamine | [Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein | decreases expression|increases abundance | 12714356 |
| D006632 | Histamine | HRH2 protein promotes the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|increases abundance|increases reaction | 12714356 |
| D006632 | Histamine | Staurosporine inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| C072551 | HS 142-1 | HS 142-1 promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 10642269 |
| C072551 | HS 142-1 | HS 142-1 promotes the reaction [Phenylephrine results in increased secretion of NPPA protein] | increases reaction|increases secretion | 10642269 |
| C072551 | HS 142-1 | HS 142-1 results in increased expression of NPPA mRNA | increases expression | 10642269 |
| C072551 | HS 142-1 | HS 142-1 results in increased secretion of NPPA protein | increases secretion | 10642269 |
| D006861 | Hydrogen Peroxide | NPPA protein results in decreased susceptibility to Hydrogen Peroxide | decreases response to substance | 10330004 |
| D019469 | Indinavir | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 11706060 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [NPPA protein affects the activity of MPO protein] | affects activity|decreases reaction | 17522345 |
| D007213 | Indomethacin | Indomethacin inhibits the reaction [NPPA protein affects the expression of TNF protein] | affects expression|decreases reaction | 17522345 |
| D007545 | Isoproterenol | EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA] | affects cotreatment|affects reaction|increases expression | 10710348 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of NPPA mRNA | increases expression | 11804996 11299230 |
| D007545 | Isoproterenol | [Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 10710348 |
| D007545 | Isoproterenol | ADRB1 protein promotes the reaction [Isoproterenol results in decreased expression of NPPA protein] | decreases expression|increases reaction | 18378355 |
| D007545 | Isoproterenol | CREM protein inhibits the reaction [Isoproterenol results in increased expression of NPPA protein] | decreases reaction|increases expression | 12791704 |
| D007545 | Isoproterenol | Isoproterenol inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18851973 |
| D007545 | Isoproterenol | Isoproterenol results in decreased expression of NPPA protein | decreases expression | 18378355 |
| D007545 | Isoproterenol | Isoproterenol results in increased expression of NPPA mRNA | increases expression | 10888249 |
| D007545 | Isoproterenol | MAP2K1 protein affects the reaction [Isoproterenol results in increased expression of NPPA mRNA] | affects reaction|increases expression | 10888249 |
| C063302 | KN 62 | KN 62 inhibits the reaction [LIF protein results in increased expression of NPPA protein] | decreases reaction|increases expression | 11073891 |
| C057416 | KT 5720 | KT 5720 inhibits the reaction [[8-Bromo Cyclic Adenosine Monophosphate results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| C057416 | KT 5720 | KT 5720 inhibits the reaction [NPPA protein results in increased secretion of CALCA protein] | decreases reaction|increases secretion | 17522345 |
| D008070 | Lipopolysaccharides | Lipopolysaccharides results in increased expression of NPPA mRNA | increases expression | 18701451 |
| D008070 | Lipopolysaccharides | NPPA protein inhibits the reaction [Lipopolysaccharides results in increased secretion of TNF protein] | decreases reaction|increases secretion | 12022755 |
| C032881 | lysophosphatidic acid | Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased expression of NPPA protein] | decreases reaction|increases expression | 15081308 |
| D008345 | Manganese | Manganese results in decreased expression of NPPA mRNA | decreases expression | 17175027 |
| C025340 | manganese chloride | manganese chloride results in decreased expression of NPPA mRNA | decreases expression | 17175027 |
| D008790 | Metoprolol | Metoprolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17592507 |
| D015735 | Mifepristone | Mifepristone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16533503 |
| D016686 | Monocrotaline | Monocrotaline results in increased expression of NPPA mRNA | increases expression | 16936438 |
| C063509 | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 18851973 |
| C481648 | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16513848 |
| C477659 | N-(3-methoxyphenyl)-4-chlorocinnamanilide | N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [NPPA protein affects the activity of MPO protein] | affects activity|decreases reaction | 17522345 |
| C477659 | N-(3-methoxyphenyl)-4-chlorocinnamanilide | N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [NPPA protein affects the expression of CALCA protein] | affects expression|decreases reaction | 17522345 |
| C477659 | N-(3-methoxyphenyl)-4-chlorocinnamanilide | N-(3-methoxyphenyl)-4-chlorocinnamanilide inhibits the reaction [NPPA protein affects the expression of TNF protein] | affects expression|decreases reaction | 17522345 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| C084956 | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966059 15452191 |
| C048599 | N(6)-cyclopentyladenosine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| C048599 | N(6)-cyclopentyladenosine | N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966059 15452191 |
| C483758 | N(6)-phenyl-cAMP | N(6)-phenyl-cAMP analog inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18851973 |
| C433446 | N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine | N-hydroxy-N'-(4-butyl-2-methylphenyl)formamidine inhibits the reaction [Benzo(a)pyrene results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19889059 |
| C007350 | nitrofen | Dexamethasone inhibits the reaction [nitrofen results in decreased expression of NPPA mRNA] | decreases expression|decreases reaction | 11584395 |
| C007350 | nitrofen | Dexamethasone inhibits the reaction [nitrofen results in decreased expression of NPPA protein] | decreases expression|decreases reaction | 11584395 |
| C007350 | nitrofen | nitrofen results in decreased expression of NPPA mRNA | decreases expression | 11584395 |
| C007350 | nitrofen | nitrofen results in decreased expression of NPPA protein | decreases expression | 11584395 |
| D026423 | S-Nitroso-N-Acetylpenicillamine | [S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084 |
| D009638 | Norepinephrine | Norepinephrine results in increased expression of NPPA mRNA | increases expression | 17266992 17592507 |
| D009638 | Norepinephrine | Propranolol promotes the reaction [Norepinephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17592507 |
| C106266 | omapatrilat | omapatrilat results in increased expression of NPPA protein | increases expression | 11762555 |
| D010100 | Oxygen | [Phenylephrine co-treated with Oxygen deficiency] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 11042672 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [AGT protein results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 10727428 |
| C093973 | PD 98059 | PD 98059 inhibits the reaction [AGT protein results in increased expression of NPPA protein] | decreases reaction|increases expression | 10727428 |
| C093973 | PD 98059 | PD 98059 results in decreased expression of NPPA protein | decreases expression | 10727428 |
| D010424 | Pentobarbital | Pentobarbital results in decreased expression of NPPA protein | decreases expression | 8464334 |
| D037342 | Pertussis Toxin | Pertussis Toxin inhibits the reaction [lysophosphatidic acid results in increased expression of NPPA protein] | decreases reaction|increases expression | 15081308 |
| D010656 | Phenylephrine | ANGPT1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18502941 |
| D010656 | Phenylephrine | DGKZ protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16380548 |
| D010656 | Phenylephrine | EGR1 protein affects the reaction [[Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA] | affects cotreatment|affects reaction|increases expression | 10710348 |
| D010656 | Phenylephrine | HEY2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16603706 |
| D010656 | Phenylephrine | JUND protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16690042 |
| D010656 | Phenylephrine | MOV10L1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 12754203 |
| D010656 | Phenylephrine | [NPPA protein results in increased activity of NPR1 protein] promotes the reaction [Phenylephrine results in increased localization of NFATC3 protein] | increases activity|increases localization|increases reaction | 15939815 |
| D010656 | Phenylephrine | [Phenylephrine co-treated with ADRA1B protein] results in increased expression of NPPA protein | affects cotreatment|increases expression | 11499749 |
| D010656 | Phenylephrine | [Phenylephrine co-treated with Isoproterenol] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 10710348 |
| D010656 | Phenylephrine | [Phenylephrine results in increased activity of ITPR2 protein] which results in increased expression of NPPA mRNA | increases activity|increases expression | 15201137 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of NPPA mRNA | increases expression | 16603706 16690042 18487437 18502941 16380548 11299230 11804996 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of NPPA protein | increases expression | 10679475 |
| D010656 | Phenylephrine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | 1,3-dipropyl-8-cyclopentylxanthine inhibits the reaction [N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| D010656 | Phenylephrine | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 12513686 |
| D010656 | Phenylephrine | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | 2,3-diethyl-4,5-dipropyl-6-phenylpyridine-3-thiocarboxylate-5-carboxylate inhibits the reaction [N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| D010656 | Phenylephrine | 2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15452191 19966059 |
| D010656 | Phenylephrine | 2-aminoethoxydiphenyl borate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16787574 |
| D010656 | Phenylephrine | 2-Chloroadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15452191 |
| D010656 | Phenylephrine | 4-(3-(2-propyl-3-hydroxy-4-acetyl)phenoxy)propyloxyphenoxy acetic acid inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15721863 |
| D010656 | Phenylephrine | 4-trifluoromethylsalicylic acid inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 16421291 |
| D010656 | Phenylephrine | 8-(3-chlorostyryl)caffeine inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | [8-((4-chlorophenyl)thio)cyclic-3',5'-GMP co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084 |
| D010656 | Phenylephrine | 8-(4-sulfophenyl)theophylline inhibits the reaction [[9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | [9-(2-hydroxy-3-nonyl)adenine co-treated with 4-nitrobenzylthioinosine] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | ADM protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11470465 |
| D010656 | Phenylephrine | ADORA1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | ADORA2A protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | ADORA3 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 19966059 |
| D010656 | Phenylephrine | Aldosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 19966502 |
| D010656 | Phenylephrine | BQ 788 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15007106 |
| D010656 | Phenylephrine | CABIN1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 10655507 |
| D010656 | Phenylephrine | CABIN1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 10655507 |
| D010656 | Phenylephrine | Caffeine analog inhibits the reaction [2-(4-(2-carboxyethyl)phenethylamino)-5'-N-ethylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression | 15452191 |
| D010656 | Phenylephrine | chelerythrine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16787574 |
| D010656 | Phenylephrine | chelerythrine promotes the reaction [2-aminoethoxydiphenyl borate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA]] | decreases reaction|increases expression|increases reaction | 16787574 |
| D010656 | Phenylephrine | Corticosterone promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 16533503 |
| D010656 | Phenylephrine | CREBBP protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 11705990 |
| D010656 | Phenylephrine | cyclo(Trp-Asp-Pro-Val-Leu) inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15007106 |
| D010656 | Phenylephrine | EP300 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 11705990 |
| D010656 | Phenylephrine | EYA2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 17327491 |
| D010656 | Phenylephrine | Forskolin inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18851973 11470465 |
| D010656 | Phenylephrine | fulvestrant inhibits the reaction [[Estradiol co-treated with Phenylephrine] results in increased expression of NPPA protein] | affects cotreatment|decreases reaction|increases expression | 14718400 |
| D010656 | Phenylephrine | GLRX3 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 16809552 |
| D010656 | Phenylephrine | [GW 501516 binds to PPARD protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects binding|decreases reaction|increases expression | 18701451 |
| D010656 | Phenylephrine | HS 142-1 promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 10642269 |
| D010656 | Phenylephrine | HS 142-1 promotes the reaction [Phenylephrine results in increased secretion of NPPA protein] | increases reaction|increases secretion | 10642269 |
| D010656 | Phenylephrine | IKBKB protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 11381115 |
| D010656 | Phenylephrine | ILK protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 16170337 |
| D010656 | Phenylephrine | Isoproterenol inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18851973 |
| D010656 | Phenylephrine | JUN gene mutant form inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11799083 |
| D010656 | Phenylephrine | KCND2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 12403671 |
| D010656 | Phenylephrine | MAP2K1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 10888249 |
| D010656 | Phenylephrine | MAPK8IP1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11513749 |
| D010656 | Phenylephrine | MBF1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein] | increases expression|increases reaction | 12729799 |
| D010656 | Phenylephrine | MEKK1 protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 10727428 |
| D010656 | Phenylephrine | Metoprolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17592507 |
| D010656 | Phenylephrine | MOV10L1 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11854500 |
| D010656 | Phenylephrine | MYOCD protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein] | increases expression|increases reaction | 14676212 |
| D010656 | Phenylephrine | N-(2-(4-bromocinnamylamino)ethyl)-5-isoquinolinesulfonamide promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 18851973 |
| D010656 | Phenylephrine | N-(2-methyl-4,5-bis(methylsulfonyl)benzoyl)guanidine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16513848 |
| D010656 | Phenylephrine | N(6)-(3-iodobenzyl)-5'-N-methylcarboxamidoadenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15452191 19966059 |
| D010656 | Phenylephrine | N(6)-cyclopentyladenosine inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966059 15452191 |
| D010656 | Phenylephrine | N(6)-phenyl-cAMP analog inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18851973 |
| D010656 | Phenylephrine | NFKBIA protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 11381115 |
| D010656 | Phenylephrine | Ouabain promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17266992 |
| D010656 | Phenylephrine | PDE5A protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 18790048 |
| D010656 | Phenylephrine | [Phenylephrine co-treated with Oxygen deficiency] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 11042672 |
| D010656 | Phenylephrine | Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter] | affects binding|decreases reaction | 19729022 |
| D010656 | Phenylephrine | Phenylephrine promotes the reaction [CTNNB1 protein binds to NPPA promoter] | affects binding|increases reaction | 19799869 |
| D010656 | Phenylephrine | Phenylephrine promotes the reaction [MYOCD protein binds to NPPA promoter] | affects binding|increases reaction | 16556869 |
| D010656 | Phenylephrine | [Phenylephrine results in increased activity of CREBBP protein] which results in increased expression of NPPA protein | increases activity|increases expression | 12477714 |
| D010656 | Phenylephrine | [Phenylephrine results in increased activity of EP300 protein] which results in increased expression of NPPA protein | increases activity|increases expression | 12477714 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of NPPA mRNA | increases expression | 17204550 11230109 16517124 18252717 12435817 15522277 18851973 16533503 16170337 15452191 11754973 16513848 10655507 19966059 19540241 16556869 14718400 10727428 11799083 16787574 10642269 15220332 11470465 17592507 15721863 11799084 10843871 17287366 17266992 19729022 15795322 15191894 19966502 16809552 10888249 18701451 17124262 12682052 11042672 17499311 18790048 11836006 11854500 |
| D010656 | Phenylephrine | Phenylephrine results in increased expression of NPPA protein | increases expression | 16421291 17327491 16809552 14718400 17124262 10727428 18378355 10655507 19540241 |
| D010656 | Phenylephrine | Phenylephrine results in increased secretion of NPPA protein | increases secretion | 12729799 12435817 10642269 11754973 |
| D010656 | Phenylephrine | [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects binding|decreases reaction|increases expression | 18701451 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 17592507 |
| D010656 | Phenylephrine | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 12513686 |
| D010656 | Phenylephrine | Propranolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17592507 |
| D010656 | Phenylephrine | RGS2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16517124 |
| D010656 | Phenylephrine | RHOA protein affects the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects reaction|increases expression | 10843871 |
| D010656 | Phenylephrine | SB 203580 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 10727428 |
| D010656 | Phenylephrine | sildenafil inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18790048 |
| D010656 | Phenylephrine | SK-7041 inhibits the reaction [Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter]] | affects binding|decreases reaction | 19729022 |
| D010656 | Phenylephrine | SK-7041 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19729022 |
| D010656 | Phenylephrine | [S-Nitroso-N-Acetylpenicillamine co-treated with PRKG1 protein alternative form] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects cotreatment|decreases reaction|increases expression | 11799084 |
| D010656 | Phenylephrine | Spironolactone inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966502 |
| D010656 | Phenylephrine | TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 19540241 |
| D010656 | Phenylephrine | TGFB1I1 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein] | increases expression|increases reaction | 19540241 |
| D010656 | Phenylephrine | trichostatin A inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19729022 |
| D010656 | Phenylephrine | triflusal inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 16421291 |
| D010656 | Phenylephrine | tyrphostin AG 1478 inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212 |
| D010656 | Phenylephrine | U 0126 inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 12513686 |
| D010656 | Phenylephrine | Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212 |
| D010656 | Phenylephrine | Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212 |
| D010656 | Phenylephrine | Uridine Triphosphate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 14676212 |
| D010656 | Phenylephrine | xestospongin C inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16787574 |
| D010656 | Phenylephrine | Y 27632 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11739382 |
| D010656 | Phenylephrine | ZFPM2 protein inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 15220332 |
| C005435 | phenylmethylpyrazolone | phenylmethylpyrazolone results in decreased expression of NPPA mRNA | decreases expression | 15824197 |
| C006253 | pirinixic acid | pirinixic acid results in increased expression of NPPA mRNA | increases expression | 17951219 |
| C006253 | pirinixic acid | [pirinixic acid binds to PPARA protein] inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | affects binding|decreases reaction|increases expression | 18701451 |
| D010936 | Plant Extracts | Plant Extracts affects the expression of NPPA mRNA | affects expression | 17645561 |
| D011224 | Prazosin | Prazosin inhibits the reaction [EDN1 protein results in increased expression of NPPA protein] | decreases reaction|increases expression | 12513686 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 17592507 |
| D011224 | Prazosin | Prazosin inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 12513686 |
| D011433 | Propranolol | Propranolol promotes the reaction [Norepinephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17592507 |
| D011433 | Propranolol | Propranolol promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17592507 |
| D011433 | Propranolol | Propranolol results in increased expression of NPPA mRNA | increases expression | 17592507 |
| D015232 | Dinoprostone | Dinoprostone results in increased expression of NPPA protein | increases expression | 18851973 |
| D015232 | Dinoprostone | Forskolin inhibits the reaction [Dinoprostone results in increased expression of NPPA protein] | decreases reaction|increases expression | 18851973 |
| C059514 | resveratrol | resveratrol affects the expression of NPPA mRNA | affects expression | 17875610 |
| C059514 | resveratrol | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19969063 |
| C059514 | resveratrol | resveratrol results in decreased expression of NPPA mRNA | decreases expression | 17499237 |
| C059514 | resveratrol | resveratrol results in decreased secretion of NPPA protein | decreases secretion | 17499237 |
| C093642 | SB 203580 | SB 203580 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 10727428 |
| C101426 | sildenafil | sildenafil inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 18790048 |
| C497103 | SK-7041 | KLF4 protein affects the reaction [SK-7041 affects the expression of NPPA mRNA] | affects expression|affects reaction | 19729022 |
| C497103 | SK-7041 | SK-7041 affects the expression of NPPA mRNA | affects expression | 19729022 |
| C497103 | SK-7041 | SK-7041 inhibits the reaction [Phenylephrine inhibits the reaction [KLF4 protein binds to NPPA promoter]] | affects binding|decreases reaction | 19729022 |
| C497103 | SK-7041 | SK-7041 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19729022 |
| D012982 | Sodium, Dietary | Dietary Sucrose promotes the reaction [Sodium, Dietary results in increased expression of NPPA mRNA] | increases expression|increases reaction | 18551017 |
| D012982 | Sodium, Dietary | Sodium, Dietary results in increased expression of NPPA mRNA | increases expression | 18551017 |
| D013148 | Spironolactone | Spironolactone inhibits the reaction [Aldosterone results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966502 |
| D013148 | Spironolactone | Spironolactone inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19966502 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [[Histamine results in increased abundance of Cyclic AMP] which results in decreased expression of NPPA protein] | decreases expression|decreases reaction|increases abundance | 18977371 |
| D019311 | Staurosporine | Staurosporine inhibits the reaction [MBF1 protein results in increased secretion of NPPA protein] | decreases reaction|increases secretion | 12729799 |
| D010042 | Ouabain | Ouabain promotes the reaction [Phenylephrine results in increased expression of NPPA mRNA] | increases expression|increases reaction | 17266992 |
| D016559 | Tacrolimus | Tacrolimus inhibits the reaction [NPR1 protein affects the expression of NPPA mRNA] | affects expression|decreases reaction | 15939815 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NPPA mRNA | increases expression | 17975115 |
| D013749 | Tetrachlorodibenzodioxin | resveratrol inhibits the reaction [Tetrachlorodibenzodioxin results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19969063 |
| D013749 | Tetrachlorodibenzodioxin | Tetrachlorodibenzodioxin results in increased expression of NPPA mRNA | increases expression | 19969063 |
| D013755 | Tetradecanoylphorbol Acetate | MAPK8IP1 protein inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11513749 |
| D013755 | Tetradecanoylphorbol Acetate | Mifepristone inhibits the reaction [Tetradecanoylphorbol Acetate results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16533503 |
| D013755 | Tetradecanoylphorbol Acetate | Tetradecanoylphorbol Acetate results in increased expression of NPPA mRNA | increases expression | 11470465 16533503 19244478 |
| C012589 | trichostatin A | trichostatin A affects the expression of NPPA mRNA | affects expression | 19729022 |
| C012589 | trichostatin A | trichostatin A inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 19729022 |
| C016167 | triflusal | triflusal inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 16421291 |
| C101044 | tyrphostin AG 1478 | tyrphostin AG 1478 inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212 |
| C113580 | U 0126 | U 0126 inhibits the reaction [Phenylephrine results in increased expression of NPPA protein] | decreases reaction|increases expression | 12513686 |
| D014544 | Uridine Triphosphate | Uridine Triphosphate inhibits the reaction [GNAQ protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212 |
| D014544 | Uridine Triphosphate | Uridine Triphosphate inhibits the reaction [MYL2 protein promotes the reaction [Phenylephrine results in increased expression of NPPA protein]] | decreases reaction|increases expression|increases reaction | 14676212 |
| D014544 | Uridine Triphosphate | Uridine Triphosphate inhibits the reaction [MYOCD protein results in increased expression of NPPA protein] | decreases reaction|increases expression | 14676212 |
| D014544 | Uridine Triphosphate | Uridine Triphosphate inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 14676212 |
| D014544 | Uridine Triphosphate | Uridine Triphosphate results in increased expression of NPPA mRNA | increases expression | 14676212 |
| C013983 | vinpocetine | vinpocetine inhibits the reaction [AGT protein inhibits the reaction [NPPA protein results in increased abundance of Cyclic GMP]] | decreases reaction|increases abundance | 11696475 |
| C511704 | xestospongin C | xestospongin C inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 16787574 |
| C108830 | Y 27632 | Y 27632 inhibits the reaction [Phenylephrine results in increased expression of NPPA mRNA] | decreases reaction|increases expression | 11739382 |
| D015215 | Zidovudine | [Zidovudine co-treated with Lamivudine co-treated with Indinavir] results in increased expression of NPPA mRNA | affects cotreatment|increases expression | 11706060 |
| D015054 | Zymosan | NPPA protein results in decreased susceptibility to Zymosan | decreases response to substance | 10330004 |
| Disease ID | Disease Name | Direct Evidence | Inference Chemical Name | Inference Score | Publication |
|---|---|---|---|---|---|
| MESH:D000014 | Abnormalities, Drug-Induced | Ethanol | 5.44 | 17676605 18926900 | |
| MESH:D000014 | Abnormalities, Drug-Induced | Tetrachlorodibenzodioxin | 5.44 | 14514962 15322242 11752688 | |
| MESH:D000138 | Acidosis | Ammonium Chloride | 7.39 | 18287403 | |
| MESH:D000138 | Acidosis | Ethanol | 7.39 | 11192467 | |
| MESH:D000163 | Acquired Immunodeficiency Syndrome | Zidovudine | 3.91 | 9612607 | |
| MESH:D000168 | Acrocephalosyndactylia | U 0126 | 4.57 | 17694057 | |
| MESH:D058186 | Acute Kidney Injury | Gentamicins | 6.30 | 11274264 | |
| MESH:D058186 | Acute Kidney Injury | resveratrol | 6.30 | 16538975 | |
| MESH:D055371 | Acute Lung Injury | Lipopolysaccharides | 10.36 | 11850527 18653653 | |
| MESH:D055371 | Acute Lung Injury | Oxygen | 10.36 | 16759491 | |
| MESH:D055371 | Acute Lung Injury | pirinixic acid | 10.36 | 18653653 | |
| MESH:D000230 | Adenocarcinoma | therapeutic | 18225537 | ||
| MESH:D000230 | Adenocarcinoma | Benzo(a)pyrene | 7.18 | 20464547 20127859 | |
| MESH:D000230 | Adenocarcinoma | Doxorubicin | 7.18 | 17418594 | |
| MESH:D000230 | Adenocarcinoma | Estradiol | 7.18 | 11473722 | |
| MESH:D000230 | Adenocarcinoma | Indomethacin | 7.18 | 16537180 | |
| MESH:D000236 | Adenoma | Benzo(a)pyrene | 10.83 | 6695378 | |
| MESH:D000236 | Adenoma | beta-Naphthoflavone | 10.83 | 19389873 | |
| MESH:D000236 | Adenoma | Indomethacin | 10.83 | 11497255 | |
| MESH:D000236 | Adenoma | resveratrol | 10.83 | 15688382 | |
| MESH:D018248 | Adenoma, Liver Cell | pirinixic acid | 6.83 | 16434500 | |
| MESH:D018248 | Adenoma, Liver Cell | Tetrachlorodibenzodioxin | 6.83 | 16835633 | |
| MESH:D011125 | Adenomatous Polyposis Coli | Dinoprostone | 4.20 | 17942926 | |
| MESH:D018246 | Adrenocortical Adenoma | Arsenic | 4.26 | 17306315 | |
| MESH:D000419 | Albuminuria | Doxorubicin | 3.65 | 21441931 | |
| MESH:D020268 | Alcohol-Induced Disorders, Nervous System | Ethanol | 4.37 | 15451040 15451039 | |
| MESH:D016301 | Alveolar Bone Loss | Indomethacin | 4.42 | 17225004 | |
| MESH:D000544 | Alzheimer Disease | Indomethacin | 4.85 | 15579461 17627676 | |
| MESH:D000544 | Alzheimer Disease | Plant Extracts | 4.85 | 16962711 | |
| MESH:D000544 | Alzheimer Disease | resveratrol | 4.85 | 16183991 16162502 | |
| MESH:D000686 | Amyloidosis | Diethylstilbestrol | 3.59 | 15469931 | |
| MESH:D000740 | Anemia | Tetrachlorodibenzodioxin | 6.24 | 11748828 | |
| MESH:D000740 | Anemia | Zymosan | 6.24 | 18664788 | |
| MESH:D000756 | Anemia, Sideroblastic | Manganese | 8.20 | 16910769 | |
| MESH:D000756 | Anemia, Sideroblastic | manganese chloride | 8.20 | 16910769 | |
| MESH:D000853 | Anophthalmos | Ethanol | 3.91 | 15513904 | |
| MESH:D000860 | Anoxia | Oxygen | 4.13 | 20872349 | |
| MESH:D001008 | Anxiety Disorders | Ethanol | 6.83 | 11141031 | |
| MESH:D001008 | Anxiety Disorders | Pentobarbital | 6.83 | 18313124 11141031 | |
| MESH:D001014 | Aortic Aneurysm | Dinoprostone | 9.24 | 10231640 | |
| MESH:D001014 | Aortic Aneurysm | Indomethacin | 9.24 | 10231640 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Benzo(a)pyrene | 14.87 | 19183758 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Dinoprostone | 14.87 | 10388637 | |
| MESH:D017544 | Aortic Aneurysm, Abdominal | Indomethacin | 14.87 | 10388637 | |
| MESH:D001145 | Arrhythmias, Cardiac | Amiodarone | 6.39 | 18218290 18057881 20041841 | |
| MESH:D001145 | Arrhythmias, Cardiac | Phenylephrine | 6.39 | 17460149 | |
| MESH:D020261 | Arsenic Poisoning | Arsenic | 2.51 | 12569548 18414634 16835338 16251483 | |
| MESH:D018771 | Arthralgia | Indomethacin | 4.22 | 2160914 | |
| MESH:D001169 | Arthritis, Experimental | Dexamethasone | 12.24 | 17659584 | |
| MESH:D001169 | Arthritis, Experimental | Plant Extracts | 12.24 | 14686799 | |
| MESH:D001169 | Arthritis, Experimental | resveratrol | 12.24 | 17115116 | |
| MESH:D001169 | Arthritis, Experimental | Zymosan | 12.24 | 15188379 15142272 15944321 17659584 16872482 | |
| MESH:D001172 | Arthritis, Rheumatoid | Indomethacin | 4.19 | 11248219 | |
| MESH:D001172 | Arthritis, Rheumatoid | phenylmethylpyrazolone | 4.19 | 16390820 | |
| MESH:D001249 | Asthma | Histamine | 3.54 | 16387687 | |
| MESH:D050197 | Atherosclerosis | Arsenic | 7.44 | 19371607 12928151 | |
| MESH:D050197 | Atherosclerosis | Oxygen | 7.44 | 16391483 | |
| MESH:D050197 | Atherosclerosis | resveratrol | 7.44 | 16873680 17967414 | |
| MESH:D001281 | Atrial Fibrillation | Amiodarone | 3.15 | 19698954 18651412 | |
| OMIM:612201 | ATRIAL FIBRILLATION, FAMILIAL, 6 | marker/mechanism | |||
| MESH:D001284 | Atrophy | fulvestrant | 3.96 | 11514358 | |
| MESH:D001321 | Autistic Disorder | Norepinephrine | 3.22 | 8570775 | |
| MESH:D001321 | Autistic Disorder | Propranolol | 3.22 | 18766980 | |
| MESH:D001477 | Bartter Syndrome | Dinoprostone | 9.67 | 15976003 | |
| MESH:D001477 | Bartter Syndrome | Indomethacin | 9.67 | 10684365 | |
| MESH:D001778 | Blood Coagulation Disorders | Amiodarone | 10.41 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | pirinixic acid | 10.41 | 19483382 | |
| MESH:D001778 | Blood Coagulation Disorders | Tetrachlorodibenzodioxin | 10.41 | 12125929 | |
| MESH:D001836 | Body Weight Changes | Tetrachlorodibenzodioxin | 2.84 | 15340226 | |
| MESH:D001848 | Bone Diseases, Developmental | Tetrachlorodibenzodioxin | 2.09 | 15746008 | |
| MESH:D019046 | Bone Marrow Neoplasms | Doxorubicin | 3.75 | 14601052 | |
| MESH:D001919 | Bradycardia | Isoproterenol | 12.55 | 6740701 | |
| MESH:D001919 | Bradycardia | Phenylephrine | 12.55 | 15306635 | |
| MESH:D001919 | Bradycardia | Propranolol | 12.55 | 6740701 | |
| MESH:D001929 | Brain Edema | Indomethacin | 4.08 | 11481608 | |
| MESH:D002545 | Brain Ischemia | Indomethacin | 11.82 | 12524144 | |
| MESH:D002545 | Brain Ischemia | Plant Extracts | 11.82 | 16041641 | |
| MESH:D002545 | Brain Ischemia | resveratrol | 11.82 | 17600658 | |
| MESH:D001932 | Brain Neoplasms | Doxorubicin | 2.99 | 17150277 | |
| MESH:D001943 | Breast Neoplasms | Benzo(a)pyrene | 4.13 | 17474063 20146248 | |
| MESH:D001943 | Breast Neoplasms | Diethylstilbestrol | 4.13 | 15324884 17129689 | |
| MESH:D001943 | Breast Neoplasms | Doxorubicin | 4.13 | 17983394 19526202 15994142 15136595 16935488 16264153 11325840 15939500 15567936 15993339 17369602 18695136 18234424 15692762 18628466 15634643 15668708 16826403 18382427 16595493 17426702 16322301 16115903 16096432 | |
| MESH:D001943 | Breast Neoplasms | Estradiol | 4.13 | 14630087 12948864 19861407 16675129 18497071 17018787 17261762 17289903 | |
| MESH:D001943 | Breast Neoplasms | fulvestrant | 4.13 | 18984771 | |
| MESH:D001943 | Breast Neoplasms | Indomethacin | 4.13 | 17401462 | |
| MESH:D001943 | Breast Neoplasms | Oxygen | 4.13 | 17263869 | |
| MESH:D001943 | Breast Neoplasms | resveratrol | 4.13 | 17651959 17534123 16393696 | |
| MESH:D001943 | Breast Neoplasms | Tetrachlorodibenzodioxin | 4.13 | 20435547 | |
| MESH:D016535 | Bronchial Hyperreactivity | tyrphostin AG 1478 | 4.12 | 12794006 | |
| MESH:D001986 | Bronchial Spasm | Histamine | 4.87 | 18298128 | |
| MESH:D002056 | Burns | Ethanol | 8.36 | 16374292 | |
| MESH:D002056 | Burns | Indomethacin | 8.36 | 10459503 | |
| MESH:D002057 | Burns, Chemical | Plant Extracts | 4.39 | 9625245 | |
| MESH:D002100 | Cachexia | Indomethacin | 4.07 | 11239499 16537180 15141370 15625704 | |
| MESH:D002181 | Candidiasis, Vulvovaginal | Estradiol | 3.53 | 16111702 | |
| MESH:D002252 | Carbon Tetrachloride Poisoning | Carbon Tetrachloride | 2.88 | 16050911 15673190 16192424 16227642 16011737 15700767 16124888 10355542 18705752 3786805 16097048 15721981 | |
| MESH:D002276 | Carcinoid Tumor | Doxorubicin | 3.86 | 16051944 | |
| MESH:D002277 | Carcinoma | Tetrachlorodibenzodioxin | 2.03 | 16835633 | |
| MESH:D002280 | Carcinoma, Basal Cell | Arsenic | 2.97 | 17687452 15504454 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Arsenic | 14.59 | 16507464 17306315 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Carbon Tetrachloride | 14.59 | 18788625 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Diethylstilbestrol | 14.59 | 16924424 15948411 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Doxorubicin | 14.59 | 17876044 18059187 16234567 16023760 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Estradiol | 14.59 | 16924424 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Ethanol | 14.59 | 18788625 15763234 15289165 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Indomethacin | 14.59 | 16391822 | |
| MESH:D006528 | Carcinoma, Hepatocellular | Plant Extracts | 14.59 | 18834353 | |
| MESH:D006528 | Carcinoma, Hepatocellular | resveratrol | 14.59 | 19321006 16227395 | |
| MESH:D018827 | Carcinoma, Lewis Lung | Indomethacin | 8.34 | 11053908 | |
| MESH:D018827 | Carcinoma, Lewis Lung | resveratrol | 8.34 | 16675471 | |
| MESH:D018276 | Carcinoma, Medullary | Indomethacin | 4.42 | 18791128 11352223 14736730 | |
| MESH:D002292 | Carcinoma, Renal Cell | Doxorubicin | 4.97 | 16201981 1485588 | |
| MESH:D002292 | Carcinoma, Renal Cell | Indomethacin | 4.97 | 17341418 | |
| MESH:D018288 | Carcinoma, Small Cell | therapeutic | 18717826 | ||
| MESH:D002294 | Carcinoma, Squamous Cell | Arsenic | 12.81 | 17687452 18922899 15504454 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Benzo(a)pyrene | 12.81 | 20419170 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Doxorubicin | 12.81 | 6189445 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Indomethacin | 12.81 | 15482327 12636206 | |
| MESH:D002294 | Carcinoma, Squamous Cell | resveratrol | 12.81 | 16227395 | |
| MESH:D002294 | Carcinoma, Squamous Cell | Tetradecanoylphorbol Acetate | 12.81 | 18922899 | |
| MESH:D002295 | Carcinoma, Transitional Cell | Arsenic | 3.25 | 18640142 | |
| MESH:D006332 | Cardiomegaly | marker/mechanism | 18056528 | ||
| MESH:D006332 | Cardiomegaly | Ethanol | 18.86 | 19332462 | |
| MESH:D006332 | Cardiomegaly | Isoproterenol | 18.86 | 7544033 11179087 | |
| MESH:D006332 | Cardiomegaly | Norepinephrine | 18.86 | 11179087 | |
| MESH:D006332 | Cardiomegaly | Phenylephrine | 18.86 | 11754973 15728586 17287366 17124262 11179087 16170337 | |
| MESH:D006332 | Cardiomegaly | Plant Extracts | 18.86 | 17645561 | |
| MESH:D006332 | Cardiomegaly | Tetrachlorodibenzodioxin | 18.86 | 18850075 18670907 16120746 | |
| MESH:D009202 | Cardiomyopathies | CHOP protocol | 9.56 | 16247790 | |
| MESH:D009202 | Cardiomyopathies | Doxorubicin | 9.56 | 16109756 17924179 17351982 17382496 16651473 17308081 16269455 16242529 18627295 16278810 17928571 17007740 17131338 15476868 17519947 17974986 16364871 16612575 16731534 16455267 15505089 17329180 15811867 16952015 15792986 | |
| MESH:D009202 | Cardiomyopathies | sildenafil | 9.56 | 15811867 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Amiodarone | 7.20 | 19225199 15710769 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Doxorubicin | 7.20 | 17334414 16243910 | |
| MESH:D002311 | Cardiomyopathy, Dilated | Metoprolol | 7.20 | 19477965 | |
| MESH:D002318 | Cardiovascular Diseases | Aldosterone | 19.24 | 11230374 | |
| MESH:D002318 | Cardiovascular Diseases | Arsenic | 19.24 | 15738583 17938729 19152805 | |
| MESH:D002318 | Cardiovascular Diseases | Hydrogen Peroxide | 19.24 | 16936243 | |
| MESH:D002318 | Cardiovascular Diseases | resveratrol | 19.24 | 15458977 | |
| MESH:D002318 | Cardiovascular Diseases | Spironolactone | 19.24 | 11230374 | |
| MESH:D002318 | Cardiovascular Diseases | Tacrolimus | 19.24 | 17703430 | |
| MESH:D002340 | Carotid Artery Diseases | Arsenic | 3.49 | 18022660 16973168 | |
| MESH:D002341 | Carotid Artery Thrombosis | Amiodarone | 4.15 | 18974383 | |
| MESH:D002375 | Catalepsy | Norepinephrine | 4.61 | 8216760 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Cyclosporine | 7.27 | 12371664 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Dinoprostone | 7.27 | 16192471 | |
| MESH:D002471 | Cell Transformation, Neoplastic | Estradiol | 7.27 | 18566989 | |
| MESH:D002543 | Cerebral Hemorrhage | phenylmethylpyrazolone | 4.92 | 19095969 | |
| MESH:D018281 | Cholangiocarcinoma | Tetrachlorodibenzodioxin | 2.35 | 16835633 | |
| MESH:D002764 | Cholecystitis | Indomethacin | 4.22 | 11181007 | |
| MESH:D002779 | Cholestasis | Cyclosporine | 5.29 | 19486331 | |
| MESH:D002779 | Cholestasis | pirinixic acid | 5.29 | 19176532 | |
| MESH:D002971 | Cleft Lip | Ethanol | 3.00 | 15513904 | |
| MESH:D002972 | Cleft Palate | Ethanol | 4.26 | 15513904 | |
| MESH:D002972 | Cleft Palate | Tetrachlorodibenzodioxin | 4.26 | 15668235 8697196 15340226 12621046 16354765 | |
| MESH:D003092 | Colitis | resveratrol | 3.23 | 16474422 | |
| MESH:D003110 | Colonic Neoplasms | Dexamethasone | 4.29 | 15824018 | |
| MESH:D003110 | Colonic Neoplasms | Indomethacin | 4.29 | 15637740 15625704 15936596 11260862 15963497 15786552 | |
| MESH:D003110 | Colonic Neoplasms | resveratrol | 4.29 | 16338953 | |
| MESH:D015179 | Colorectal Neoplasms | Azacitidine | 3.58 | 19934284 | |
| MESH:D015179 | Colorectal Neoplasms | Doxorubicin | 3.58 | 18802399 18259882 | |
| MESH:D015179 | Colorectal Neoplasms | Indomethacin | 3.58 | 18059344 12606626 17054584 11197048 | |
| MESH:D015179 | Colorectal Neoplasms | resveratrol | 3.58 | 16550006 | |
| MESH:D000013 | Congenital Abnormalities | Tetrachlorodibenzodioxin | 2.25 | 17141729 14669216 | |
| MESH:D003327 | Coronary Disease | resveratrol | 3.08 | 16507316 | |
| MESH:D018352 | Coronavirus Infections | Indomethacin | 4.77 | 17302372 | |
| MESH:D019465 | Craniofacial Abnormalities | Dexamethasone | 4.01 | 17728286 | |
| MESH:D019465 | Craniofacial Abnormalities | Ethanol | 4.01 | 15513904 19302082 11873399 11198716 15451040 15451039 10194807 | |
| MESH:D019465 | Craniofacial Abnormalities | nitrofen | 4.01 | 11405365 | |
| MESH:D019465 | Craniofacial Abnormalities | Tetrachlorodibenzodioxin | 4.01 | 10048152 20055451 15322242 | |
| MESH:D003456 | Cryptorchidism | Diethylstilbestrol | 3.66 | 12952375 16002989 | |
| MESH:D003550 | Cystic Fibrosis | sildenafil | 4.57 | 19747007 | |
| MESH:D017449 | Dermatitis, Allergic Contact | cobaltous chloride | 4.62 | 15059100 16823706 11298694 | |
| MESH:D017449 | Dermatitis, Allergic Contact | Dexamethasone | 4.62 | 12438553 | |
| MESH:D003876 | Dermatitis, Atopic | pirinixic acid | 1.89 | 18249437 | |
| MESH:D003921 | Diabetes Mellitus, Experimental | resveratrol | 2.99 | 16873680 | |
| MESH:D003924 | Diabetes Mellitus, Type 2 | Tetrachlorodibenzodioxin | 1.38 | 17107852 | |
| MESH:D003928 | Diabetic Nephropathies | Estradiol | 10.47 | 19279558 | |
| MESH:D003928 | Diabetic Nephropathies | Plant Extracts | 10.47 | 19706694 | |
| MESH:D003928 | Diabetic Nephropathies | resveratrol | 10.47 | 16286809 | |
| MESH:D003967 | Diarrhea | Dexamethasone | 8.48 | 7237001 | |
| MESH:D003967 | Diarrhea | Dinoprostone | 8.48 | 11488427 7237001 10446763 | |
| MESH:D003967 | Diarrhea | Indomethacin | 8.48 | 7237001 7907874 | |
| MESH:D056486 | Drug-Induced Liver Injury | Amiodarone | 9.99 | 18218290 15265979 | |
| MESH:D056486 | Drug-Induced Liver Injury | Carbon Tetrachloride | 9.99 | 7440962 2869522 16227642 7179309 16177239 7120509 19085960 10092053 15968718 11566570 17522070 3786805 3732212 15998439 6623471 21278145 4309450 19336974 10915739 15027814 9327722 6884620 | |
| MESH:D056486 | Drug-Induced Liver Injury | Doxorubicin | 9.99 | 17416283 | |
| MESH:D056486 | Drug-Induced Liver Injury | Ethanol | 9.99 | 11566570 | |
| MESH:D056486 | Drug-Induced Liver Injury | Prazosin | 9.99 | 18071297 | |
| MESH:D056486 | Drug-Induced Liver Injury | Tetrachlorodibenzodioxin | 9.99 | 20420201 | |
| MESH:D004362 | Drug Toxicity | Doxorubicin | 22.49 | 18602426 | |
| MESH:D004362 | Drug Toxicity | Gentamicins | 22.49 | 15033597 11033412 | |
| MESH:D004362 | Drug Toxicity | Lamivudine | 22.49 | 15040536 | |
| MESH:D004362 | Drug Toxicity | phenylmethylpyrazolone | 22.49 | 12649298 12231392 | |
| MESH:D004362 | Drug Toxicity | Tetrachlorodibenzodioxin | 22.49 | 11462148 | |
| MESH:D004362 | Drug Toxicity | Zidovudine | 22.49 | 15040536 | |
| MESH:D004374 | Ductus Arteriosus, Patent | Indomethacin | 4.22 | 16326151 18446180 17190690 18043480 16133044 12774134 | |
| MESH:D004381 | Duodenal Ulcer | Indomethacin | 6.89 | 11535926 11991626 11595431 17329845 17045617 17151854 17202747 17351913 10671773 11595415 16699067 | |
| MESH:D004381 | Duodenal Ulcer | Tacrolimus | 6.89 | 17202747 | |
| MESH:D050171 | Dyslipidemias | Fenofibrate | 3.70 | 16707586 | |
| MESH:D004417 | Dyspnea | Oxygen | 3.90 | 20016425 | |
| MESH:D004485 | Eczema | Dexamethasone | 3.57 | 12438553 | |
| MESH:D004487 | Edema | Cimetidine | 31.67 | 19703484 | |
| MESH:D004487 | Edema | Dexamethasone | 31.67 | 19703484 | |
| MESH:D004487 | Edema | Indomethacin | 31.67 | 7990266 7907874 8273558 19703484 16100529 8985016 10653021 | |
| MESH:D004487 | Edema | pirinixic acid | 31.67 | 12083418 | |
| MESH:D004487 | Edema | Plant Extracts | 31.67 | 12787963 | |
| MESH:D004487 | Edema | resveratrol | 31.67 | 8985016 | |
| MESH:D004487 | Edema | Staurosporine | 31.67 | 8273558 | |
| MESH:D004487 | Edema | Tetrachlorodibenzodioxin | 31.67 | 12711302 11000095 | |
| MESH:D004487 | Edema | Tetradecanoylphorbol Acetate | 31.67 | 8113982 11698051 7812673 15177302 16716910 8273558 9599246 | |
| MESH:D004487 | Edema | Zymosan | 31.67 | 7907874 | |
| MESH:D004489 | Edema, Cardiac | Tetrachlorodibenzodioxin | 2.95 | 15322242 16714409 18230668 | |
| MESH:D004681 | Encephalomyelitis, Autoimmune, Experimental | resveratrol | 3.15 | 17872969 | |
| MESH:D004701 | Endocrine Gland Neoplasms | trichostatin A | 4.69 | 19294695 | |
| MESH:D004714 | Endometrial Hyperplasia | Diethylstilbestrol | 3.76 | 16402032 | |
| MESH:D016889 | Endometrial Neoplasms | Diethylstilbestrol | 12.23 | 16804899 15700306 | |
| MESH:D016889 | Endometrial Neoplasms | Doxorubicin | 12.23 | 17359293 | |
| MESH:D016889 | Endometrial Neoplasms | Estradiol | 12.23 | 18566989 11473722 19148513 | |
| MESH:D016889 | Endometrial Neoplasms | Fenofibrate | 12.23 | 16569247 | |
| MESH:D004715 | Endometriosis | Indomethacin | 10.59 | 15652904 | |
| MESH:D004715 | Endometriosis | Mifepristone | 10.59 | 16134523 | |
| MESH:D004715 | Endometriosis | Tetrachlorodibenzodioxin | 10.59 | 10568697 9294722 | |
| MESH:D004719 | Endomyocardial Fibrosis | Doxorubicin | 10.91 | 18037988 | |
| MESH:D004719 | Endomyocardial Fibrosis | Plant Extracts | 10.91 | 15268973 | |
| MESH:D019446 | Endotoxemia | Indomethacin | 12.42 | 18509659 | |
| MESH:D019446 | Endotoxemia | Lipopolysaccharides | 12.42 | 15821434 17637181 15328337 | |
| MESH:D019446 | Endotoxemia | phenylmethylpyrazolone | 12.42 | 12954792 | |
| MESH:D004751 | Enteritis | Clonidine | 8.91 | 8982514 | |
| MESH:D004751 | Enteritis | Indomethacin | 8.91 | 16328016 17763956 10567023 | |
| MESH:D020345 | Enterocolitis, Necrotizing | Indomethacin | 9.34 | 17980183 | |
| MESH:D020345 | Enterocolitis, Necrotizing | resveratrol | 9.34 | 17923197 | |
| MESH:D004802 | Eosinophilia | Histamine | 6.55 | 12689652 | |
| MESH:D004802 | Eosinophilia | Indomethacin | 6.55 | 11298111 | |
| MESH:D004827 | Epilepsy | Norepinephrine | 5.53 | 821787 | |
| MESH:D004827 | Epilepsy | Plant Extracts | 5.53 | 19439326 19700373 | |
| MESH:D007172 | Erectile Dysfunction | sildenafil | 4.91 | 16368379 | |
| MESH:D004938 | Esophageal Neoplasms | Benzo(a)pyrene | 5.23 | 16530937 | |
| MESH:D004938 | Esophageal Neoplasms | Ethanol | 5.23 | 16704527 | |
| MESH:D004938 | Esophageal Neoplasms | Indomethacin | 5.23 | 11005569 | |
| MESH:D005124 | Eye Abnormalities | Tetrachlorodibenzodioxin | 2.27 | 11564622 | |
| MESH:D005234 | Fatty Liver | Amiodarone | 33.26 | 14986274 | |
| MESH:D005234 | Fatty Liver | Carbon Tetrachloride | 33.26 | 16045604 15959796 12631006 17595544 19224547 61145 16239168 12795759 | |
| MESH:D005234 | Fatty Liver | Cyclosporine | 33.26 | 19224547 | |
| MESH:D005234 | Fatty Liver | Dietary Sucrose | 33.26 | 17967931 | |
| MESH:D005234 | Fatty Liver | Ethanol | 33.26 | 16409862 18620774 19236843 | |
| MESH:D005234 | Fatty Liver | phenylmethylpyrazolone | 33.26 | 12795759 | |
| MESH:D005234 | Fatty Liver | pirinixic acid | 33.26 | 19236843 20131406 | |
| MESH:D005234 | Fatty Liver | Plant Extracts | 33.26 | 15975614 | |
| MESH:D005234 | Fatty Liver | Zidovudine | 33.26 | 18299183 | |
| MESH:D005235 | Fatty Liver, Alcoholic | Ethanol | 4.71 | 17920746 | |
| MESH:D052776 | Female Urogenital Diseases | Diethylstilbestrol | 3.00 | 16534752 16611131 16513791 15751030 16002989 | |
| MESH:D005310 | Fetal Alcohol Syndrome | Ethanol | 4.36 | 16946407 10194807 15451040 15513904 | |
| MESH:D005313 | Fetal Death | Tetrachlorodibenzodioxin | 2.55 | 11858732 | |
| MESH:D005334 | Fever | Dinoprostone | 10.65 | 16997862 11852909 | |
| MESH:D005334 | Fever | Indomethacin | 10.65 | 10431976 17627676 11852909 | |
| MESH:D005334 | Fever | Lipopolysaccharides | 10.65 | 11852909 9205823 | |
| MESH:D018222 | Fibromatosis, Aggressive | Doxorubicin | 3.66 | 19069698 | |
| MESH:D005354 | Fibrosarcoma | Indomethacin | 3.96 | 10962813 | |
| MESH:D005355 | Fibrosis | Carbon Tetrachloride | 13.79 | 18705752 | |
| MESH:D005355 | Fibrosis | Cyclosporine | 13.79 | 12168785 12639820 | |
| MESH:D005355 | Fibrosis | Indomethacin | 13.79 | 17994277 | |
| MESH:D005355 | Fibrosis | Tetrachlorodibenzodioxin | 13.79 | 20067830 | |
| MESH:D005499 | Folliculitis | Indomethacin | 4.22 | 11298111 | |
| MESH:D005534 | Foot Diseases | Arsenic | 4.61 | 6392382 | |
| MESH:D005739 | Gas Poisoning | Oxygen | 4.27 | 20016425 | |
| MESH:D005756 | Gastritis | Ethanol | 8.39 | 15046732 | |
| MESH:D005756 | Gastritis | Indomethacin | 8.39 | 15046732 | |
| MESH:D005833 | Genital Neoplasms, Female | Diethylstilbestrol | 4.01 | 16452187 | |
| MESH:D005885 | Gingival Hyperplasia | Cyclosporine | 3.29 | 8708960 | |
| MESH:D005909 | Glioblastoma | Doxorubicin | 11.45 | 17150277 | |
| MESH:D005909 | Glioblastoma | Indomethacin | 11.45 | 12870263 | |
| MESH:D005909 | Glioblastoma | Manganese | 11.45 | 17043766 | |
| MESH:D005909 | Glioblastoma | trichostatin A | 11.45 | 18801729 | |
| MESH:D005910 | Glioma | Indomethacin | 2.76 | 16487511 18371953 | |
| MESH:D015432 | Glomerulonephritis, Membranoproliferative | Spironolactone | 5.11 | 16928621 | |
| MESH:D005923 | Glomerulosclerosis, Focal Segmental | Indomethacin | 3.50 | 11849393 | |
| MESH:D006058 | Gonadal Disorders | Tetrachlorodibenzodioxin | 3.64 | 10696789 | |
| MESH:D006073 | Gout | Indomethacin | 4.42 | 11248219 | |
| MESH:D006086 | Graft vs Host Disease | Tacrolimus | 4.96 | 16376943 | |
| MESH:D006130 | Growth Disorders | Tacrolimus | 4.24 | 11041285 | |
| MESH:D006258 | Head and Neck Neoplasms | Doxorubicin | 5.73 | 15692506 | |
| MESH:D006258 | Head and Neck Neoplasms | Indomethacin | 5.73 | 15482327 | |
| MESH:D034381 | Hearing Loss | Gentamicins | 4.07 | 18024279 15968427 19130971 17868369 | |
| MESH:D006330 | Heart Defects, Congenital | Benzo(a)pyrene | 7.80 | 20471113 | |
| MESH:D006330 | Heart Defects, Congenital | nitrofen | 7.80 | 16080930 | |
| MESH:D006330 | Heart Defects, Congenital | Tetrachlorodibenzodioxin | 7.80 | 11294989 10048152 | |
| MESH:D006331 | Heart Diseases | Doxorubicin | 2.79 | 16144979 18006777 16879835 17875725 16707910 16495754 16244371 14766674 16330681 16244372 17888722 18674790 12587719 | |
| MESH:D006333 | Heart Failure | Doxorubicin | 15.27 | 17481944 | |
| MESH:D006333 | Heart Failure | Isoproterenol | 15.27 | 18097624 | |
| MESH:D006333 | Heart Failure | pirinixic acid | 15.27 | 20558911 | |
| MESH:D006333 | Heart Failure | Plant Extracts | 15.27 | 18097624 | |
| MESH:D006333 | Heart Failure | Propranolol | 15.27 | 20082655 | |
| MESH:D006394 | Hemangiosarcoma | Doxorubicin | 3.06 | 15692506 | |
| MESH:D006402 | Hematologic Diseases | Zidovudine | 3.84 | 12579204 | |
| MESH:D006457 | Hemoglobinuria, Paroxysmal | Cyclosporine | 3.49 | 15720958 | |
| MESH:D006463 | Hemolytic-Uremic Syndrome | Lipopolysaccharides | 3.55 | 16366002 | |
| MESH:D006470 | Hemorrhage | Tetrachlorodibenzodioxin | 2.48 | 11000095 | |
| MESH:D006501 | Hepatic Encephalopathy | Indomethacin | 3.72 | 15633222 | |
| MESH:D006505 | Hepatitis | Caffeine | 10.87 | 11394713 | |
| MESH:D006505 | Hepatitis | Carbon Tetrachloride | 10.87 | 19110552 19900420 | |
| MESH:D006505 | Hepatitis | Zymosan | 10.87 | 19110552 | |
| MESH:D006509 | Hepatitis B | Lamivudine | 4.24 | 17703166 | |
| MESH:D019694 | Hepatitis B, Chronic | Lamivudine | 4.24 | 12044531 15631357 16476009 15309715 15274664 | |
| MESH:D019698 | Hepatitis C, Chronic | Indomethacin | 3.79 | 15135802 | |
| MESH:D006529 | Hepatomegaly | Amiodarone | 13.39 | 15265979 | |
| MESH:D006529 | Hepatomegaly | pirinixic acid | 13.39 | 19176532 19772884 18467677 16221962 | |
| MESH:D006529 | Hepatomegaly | Propranolol | 13.39 | 16371745 | |
| MESH:D006529 | Hepatomegaly | Tetrachlorodibenzodioxin | 13.39 | 16120746 15340226 12621046 | |
| MESH:D006548 | Hernia, Diaphragmatic | marker/mechanism | 11584395 | ||
| MESH:D006548 | Hernia, Diaphragmatic | Dexamethasone | 4.92 | 7520565 | |
| MESH:D006548 | Hernia, Diaphragmatic | nitrofen | 4.92 | 15578192 10370017 11584395 15707848 11409163 16490937 12021965 15136996 18280292 8863223 9859898 11588001 15185205 12547725 10898224 16473863 15088113 16080930 11057544 12194112 11076806 9476886 12407540 10898222 10541330 17270546 16720372 15764645 17245593 16292651 11329586 10359170 7576705 11685700 9698600 12505043 10646786 11051153 12904592 17618886 15756563 12746050 7520565 9473106 10370016 9575882 12759764 7760232 10693666 18280291 15793718 16863852 18958481 | |
| MESH:D006558 | Herpes Genitalis | Estradiol | 4.08 | 15709030 | |
| MESH:D006561 | Herpes Simplex | Plant Extracts | 7.05 | 10715843 | |
| MESH:D006561 | Herpes Simplex | resveratrol | 7.05 | 16876885 | |
| MESH:D015658 | HIV Infections | Indinavir | 10.61 | 15388451 11141242 11363243 | |
| MESH:D015658 | HIV Infections | Lamivudine | 10.61 | 17530837 11141242 20032539 9296927 | |
| MESH:D015658 | HIV Infections | Plant Extracts | 10.61 | 12878215 | |
| MESH:D015658 | HIV Infections | Zidovudine | 10.61 | 17358032 20032539 11141242 11363243 11698656 | |
| MESH:D006689 | Hodgkin Disease | Doxorubicin | 2.64 | 17606976 15147373 18501091 | |
| MESH:D019584 | Hot Flashes | Estradiol | 7.21 | 17088409 | |
| MESH:D019584 | Hot Flashes | Plant Extracts | 7.21 | 16566672 17454163 14716179 | |
| MESH:D006869 | Hydronephrosis | Tetrachlorodibenzodioxin | 3.10 | 16354765 15340226 16959395 18606429 8697196 | |
| MESH:D006930 | Hyperalgesia | Dinoprostone | 12.54 | 16793879 | |
| MESH:D006930 | Hyperalgesia | Ethanol | 12.54 | 18783367 | |
| MESH:D006930 | Hyperalgesia | Indomethacin | 12.54 | 12727271 | |
| MESH:D006930 | Hyperalgesia | Prazosin | 12.54 | 12727271 | |
| MESH:D034321 | Hyperamylasemia | Indomethacin | 4.77 | 17883296 | |
| MESH:D006932 | Hyperbilirubinemia | Carbon Tetrachloride | 3.60 | 16899240 | |
| MESH:D053565 | Hypercalciuria | Gentamicins | 4.77 | 17652376 | |
| MESH:D006937 | Hypercholesterolemia | Amiodarone | 6.51 | 8137927 9751232 | |
| MESH:D006937 | Hypercholesterolemia | resveratrol | 6.51 | 17188708 | |
| MESH:D006940 | Hyperemia | Indomethacin | 4.07 | 12524144 | |
| MESH:D006943 | Hyperglycemia | pirinixic acid | 2.36 | 20558911 | |
| MESH:D020138 | Hyperhomocysteinemia | Plant Extracts | 3.65 | 16484555 | |
| MESH:D017488 | Hyperkeratosis, Epidermolytic | Arsenic | 3.62 | 17050553 | |
| MESH:D006949 | Hyperlipidemias | Indomethacin | 10.63 | 17546600 | |
| MESH:D006949 | Hyperlipidemias | Plant Extracts | 10.63 | 15268973 15975614 | |
| MESH:D006949 | Hyperlipidemias | resveratrol | 10.63 | 16873680 | |
| MESH:D006965 | Hyperplasia | Diethylstilbestrol | 3.53 | 14722030 12960047 | |
| MESH:D006973 | Hypertension | marker/mechanism | 19219041 | ||
| MESH:D006973 | Hypertension | Arsenic | 21.03 | 11953799 16076760 9931084 | |
| MESH:D006973 | Hypertension | CGS 35601 | 21.03 | 16364833 | |
| MESH:D006973 | Hypertension | Cyclosporine | 21.03 | 10903974 | |
| MESH:D006973 | Hypertension | Dexamethasone | 21.03 | 17042910 | |
| MESH:D006973 | Hypertension | Ouabain | 21.03 | 18976649 | |
| MESH:D006973 | Hypertension | Phenylephrine | 21.03 | 12717712 8949925 | |
| MESH:D006973 | Hypertension | Sodium, Dietary | 21.03 | 16870316 | |
| MESH:D006973 | Hypertension | Tetrachlorodibenzodioxin | 21.03 | 18670907 18850075 | |
| MESH:D006975 | Hypertension, Portal | candoxatrilat | 9.01 | 16085334 | |
| MESH:D006975 | Hypertension, Portal | Carbon Tetrachloride | 9.01 | 15338365 | |
| MESH:D046110 | Hypertension, Pregnancy-Induced | Clonidine | 5.25 | 16612254 | |
| MESH:D006976 | Hypertension, Pulmonary | cyclo(Trp-Asp-Pro-Val-Leu) | 7.06 | 16327149 | |
| MESH:D006976 | Hypertension, Pulmonary | Monocrotaline | 7.06 | 17042913 16936438 14726295 | |
| MESH:D006984 | Hypertrophy | Isoproterenol | 8.17 | 12791704 | |
| MESH:D006984 | Hypertrophy | Phenylephrine | 8.17 | 18502941 12791704 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | phenylmethylpyrazolone | 8.01 | 15824197 | |
| MESH:D017379 | Hypertrophy, Left Ventricular | resveratrol | 8.01 | 17488730 | |
| MESH:D006987 | Hypesthesia | Arsenic | 4.61 | 16093927 | |
| MESH:D020514 | Hypokalemic Periodic Paralysis | Spironolactone | 5.23 | 19822448 | |
| MESH:C537153 | Hypomagnesemia primary | Tacrolimus | 5.22 | 11041285 | |
| MESH:D007021 | Hypospadias | Diethylstilbestrol | 3.67 | 16002989 | |
| MESH:D007022 | Hypotension | Isoproterenol | 14.75 | 6740701 | |
| MESH:D007022 | Hypotension | Norepinephrine | 14.75 | 6740701 | |
| MESH:D007022 | Hypotension | Propranolol | 14.75 | 6740701 | |
| MESH:D007022 | Hypotension | Tacrolimus | 14.75 | 11041285 | |
| MESH:D007037 | Hypothyroidism | Amiodarone | 3.60 | 18020914 17991464 | |
| MESH:D007077 | Ileal Diseases | Indomethacin | 4.08 | 18306037 10574470 | |
| MESH:D007079 | Ileitis | Indomethacin | 4.42 | 10651667 10647630 16133968 | |
| MESH:D007235 | Infant, Premature, Diseases | Indomethacin | 4.42 | 16133044 | |
| MESH:D020244 | Infarction, Middle Cerebral Artery | resveratrol | 3.73 | 17600658 | |
| MESH:D007246 | Infertility | Diethylstilbestrol | 3.46 | 15036965 | |
| MESH:D007248 | Infertility, Male | fulvestrant | 3.09 | 11514358 | |
| MESH:D007249 | Inflammation | Dexamethasone | 18.31 | 8960868 11099482 | |
| MESH:D007249 | Inflammation | Indomethacin | 18.31 | 12568917 3291741 7812673 | |
| MESH:D007249 | Inflammation | Lipopolysaccharides | 18.31 | 17237260 9205823 17963957 12878042 17255318 | |
| MESH:D007249 | Inflammation | Plant Extracts | 18.31 | 16366677 12787963 19332304 15997105 | |
| MESH:D007249 | Inflammation | resveratrol | 18.31 | 16366677 | |
| MESH:D007249 | Inflammation | Tetrachlorodibenzodioxin | 18.31 | 12878042 12200463 | |
| MESH:D007249 | Inflammation | Tetradecanoylphorbol Acetate | 18.31 | 11698051 7812673 15177302 8273558 7562506 | |
| MESH:D007249 | Inflammation | Zymosan | 18.31 | 8014878 11289658 | |
| MESH:D007251 | Influenza, Human | resveratrol | 3.60 | 16624496 | |
| MESH:D007333 | Insulin Resistance | Estradiol | 4.92 | 16393666 16627594 | |
| MESH:D007333 | Insulin Resistance | pirinixic acid | 4.92 | 16306350 | |
| MESH:D007410 | Intestinal Diseases | Indomethacin | 3.42 | 11855677 11713966 18236018 10210152 11686837 15610444 15831440 17329856 17994277 | |
| MESH:D007414 | Intestinal Neoplasms | Plant Extracts | 3.79 | 12628509 12584176 12351151 | |
| MESH:D002532 | Intracranial Aneurysm | phenylmethylpyrazolone | 4.46 | 19381132 | |
| MESH:D019586 | Intracranial Hypertension | Indomethacin | 4.42 | 15241188 | |
| MESH:D019189 | Iron Metabolism Disorders | Lipopolysaccharides | 3.76 | 17255318 | |
| MESH:D043183 | Irritable Bowel Syndrome | Zymosan | 4.90 | 17553498 | |
| MESH:D007511 | Ischemia | phenylmethylpyrazolone | 4.64 | 16301206 | |
| MESH:D007569 | Jaw Abnormalities | Ethanol | 7.29 | 15513904 | |
| MESH:D007569 | Jaw Abnormalities | Tetrachlorodibenzodioxin | 7.29 | 16580747 | |
| MESH:D007579 | Jejunal Diseases | Indomethacin | 4.08 | 16133968 10574470 18306037 | |
| MESH:D007638 | Keratoconjunctivitis Sicca | Cyclosporine | 3.49 | 15604871 | |
| MESH:D007642 | Keratosis | Arsenic | 4.06 | 12749816 16930632 | |
| MESH:D007673 | Kidney Cortex Necrosis | Gentamicins | 4.78 | 18842672 | |
| MESH:D007674 | Kidney Diseases | Cyclosporine | 19.27 | 8314463 18776723 10903974 | |
| MESH:D007674 | Kidney Diseases | Doxorubicin | 19.27 | 15699352 16775033 15369732 | |
| MESH:D007674 | Kidney Diseases | Estradiol | 19.27 | 15618244 | |
| MESH:D007674 | Kidney Diseases | Gentamicins | 19.27 | 17934191 18289764 19349640 | |
| MESH:D007674 | Kidney Diseases | Indomethacin | 19.27 | 17190690 | |
| MESH:D007674 | Kidney Diseases | phenylmethylpyrazolone | 19.27 | 18085390 | |
| MESH:D007674 | Kidney Diseases | Tacrolimus | 19.27 | 11041285 | |
| MESH:D007676 | Kidney Failure, Chronic | Doxorubicin | 7.30 | 16707910 | |
| MESH:D007676 | Kidney Failure, Chronic | Hydrogen Peroxide | 7.30 | 16518626 | |
| MESH:D007680 | Kidney Neoplasms | Cyclosporine | 11.38 | 12371664 | |
| MESH:D007680 | Kidney Neoplasms | Diethylstilbestrol | 11.38 | 16762066 14681315 15003126 | |
| MESH:D007680 | Kidney Neoplasms | Estradiol | 11.38 | 15610895 | |
| MESH:D007680 | Kidney Neoplasms | Zidovudine | 11.38 | 12579204 | |
| MESH:D007683 | Kidney Tubular Necrosis, Acute | Gentamicins | 4.44 | 11231351 | |
| MESH:D007859 | Learning Disorders | Diethylstilbestrol | 6.78 | 17184923 | |
| MESH:D007859 | Learning Disorders | Ethanol | 6.78 | 15451040 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Gentamicins | 6.25 | 10219319 | |
| MESH:D016773 | Leishmaniasis, Cutaneous | Indomethacin | 6.25 | 10320625 12228301 11703811 | |
| MESH:D007938 | Leukemia | Azacitidine | 3.15 | 19148494 | |
| MESH:D004915 | Leukemia, Erythroblastic, Acute | Doxorubicin | 4.21 | 16085563 | |
| MESH:D015459 | Leukemia-Lymphoma, Adult T-Cell | Zidovudine | 3.57 | 20370541 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | PD 98059 | 9.00 | 16972261 | |
| MESH:D007948 | Leukemia, Monocytic, Acute | U 0126 | 9.00 | 16972261 | |
| MESH:D015464 | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | Indomethacin | 3.19 | 16572323 15631656 10785260 | |
| MESH:D007951 | Leukemia, Myeloid | Azacitidine | 3.78 | 19077051 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 6.54 | 16467208 17077328 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Azacitidine | 6.54 | 17596541 18720364 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | Indomethacin | 6.54 | 18360721 | |
| MESH:D015470 | Leukemia, Myeloid, Acute | trichostatin A | 6.54 | 18206229 | |
| MESH:D054429 | Leukemia, Myelomonocytic, Juvenile | Azacitidine | 4.31 | 19299654 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 9.13 | 17077328 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | Arsenic | 9.13 | 17339181 | |
| MESH:D015473 | Leukemia, Promyelocytic, Acute | resveratrol | 9.13 | 16087638 | |
| MESH:D007964 | Leukocytosis | Indomethacin | 4.42 | 16537180 | |
| MESH:D007969 | Leukomalacia, Periventricular | Indomethacin | 4.77 | 17980183 | |
| MESH:D007970 | Leukopenia | Lipopolysaccharides | 3.77 | 15821434 | |
| MESH:D017880 | Limb Deformities, Congenital | Ethanol | 3.09 | 17676605 | |
| MESH:D008064 | Lipidoses | Amiodarone | 2.80 | 15342952 17567588 | |
| MESH:D008101 | Liver Abscess, Amebic | Indomethacin | 4.77 | 11479899 | |
| MESH:D008103 | Liver Cirrhosis | Carbon Tetrachloride | 7.65 | 17174718 16943688 16221502 16239168 17157831 11408273 17334410 11903743 21278145 | |
| MESH:D008103 | Liver Cirrhosis | Ethanol | 7.65 | 15289165 | |
| MESH:D008103 | Liver Cirrhosis | Plant Extracts | 7.65 | 17157831 | |
| MESH:D008104 | Liver Cirrhosis, Alcoholic | Ethanol | 4.16 | 18295389 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Carbon Tetrachloride | 22.51 | 18251166 15996030 18412020 18166357 17481882 15876570 15338365 16033810 17557913 14724832 12632514 18205269 17823541 18481824 17922224 13678700 15730626 11481614 17698563 12632512 12445418 17708605 12898905 12586293 18317297 15123356 15370692 18187930 12649538 15818738 17565644 12741479 15931870 12958196 17805973 17631135 12389079 18279442 16011737 15057751 17976157 18705752 12666154 16192424 18277467 14716833 16136751 17944888 14748882 16027843 16638106 18339082 16248980 18156304 18210741 10355542 15673190 18429990 18054572 18395095 15893842 12609069 18395914 17761835 17714472 18420326 12546737 15052691 15959796 20821823 16116963 18418968 14716496 12667390 14512876 17900296 16015684 17766677 18376398 15362042 18472094 17525996 15925388 12445421 18263696 17721639 15650968 17640975 18006644 16097048 17869086 18472332 14620537 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dexamethasone | 22.51 | 16718785 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Dinoprostone | 22.51 | 15816358 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Doxorubicin | 22.51 | 16595196 16439617 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Estradiol | 22.51 | 14716833 14659978 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Ethanol | 22.51 | 18166357 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Fenofibrate | 22.51 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Indomethacin | 22.51 | 18194892 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Lipopolysaccharides | 22.51 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | pirinixic acid | 22.51 | 15474484 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Plant Extracts | 22.51 | 15479170 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Tetrachlorodibenzodioxin | 22.51 | 12878042 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | vinpocetine | 22.51 | 18277467 | |
| MESH:D008106 | Liver Cirrhosis, Experimental | Y 27632 | 22.51 | 13678700 | |
| MESH:D008107 | Liver Diseases | Arsenic | 6.46 | 11134558 | |
| MESH:D008107 | Liver Diseases | Carbon Tetrachloride | 6.46 | 16246199 15720792 15830285 16964402 17285989 | |
| MESH:D008107 | Liver Diseases | Dinoprostone | 6.46 | 15816358 | |
| MESH:D008107 | Liver Diseases | Plant Extracts | 6.46 | 17034775 | |
| MESH:D008108 | Liver Diseases, Alcoholic | Ethanol | 3.74 | 17347304 17207112 | |
| MESH:D017093 | Liver Failure | Carbon Tetrachloride | 3.25 | 15123358 | |
| MESH:D017114 | Liver Failure, Acute | Carbon Tetrachloride | 2.86 | 14706259 16899240 | |
| MESH:D008113 | Liver Neoplasms | Arsenic | 23.74 | 16368122 | |
| MESH:D008113 | Liver Neoplasms | Benzo(a)pyrene | 23.74 | 20195826 21137059 | |
| MESH:D008113 | Liver Neoplasms | beta-Naphthoflavone | 23.74 | 19389873 21295105 | |
| MESH:D008113 | Liver Neoplasms | Carbon Tetrachloride | 23.74 | 19294768 | |
| MESH:D008113 | Liver Neoplasms | Diethylstilbestrol | 23.74 | 16712894 15890375 | |
| MESH:D008113 | Liver Neoplasms | Fenofibrate | 23.74 | 18978307 | |
| MESH:D008113 | Liver Neoplasms | pirinixic acid | 23.74 | 16377806 20007298 15890375 | |
| MESH:D008113 | Liver Neoplasms | Plant Extracts | 23.74 | 19168119 | |
| MESH:D008113 | Liver Neoplasms | resveratrol | 23.74 | 19812893 19321006 19073162 20405173 | |
| MESH:D008113 | Liver Neoplasms | Tetrachlorodibenzodioxin | 23.74 | 16984957 | |
| MESH:D008114 | Liver Neoplasms, Experimental | beta-Naphthoflavone | 11.70 | 18164116 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Carbon Tetrachloride | 11.70 | 12014681 15583823 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Doxorubicin | 11.70 | 16842330 17085340 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Fenofibrate | 11.70 | 18253720 18775883 | |
| MESH:D008114 | Liver Neoplasms, Experimental | Tetrachlorodibenzodioxin | 11.70 | 12151625 | |
| MESH:D008133 | Long QT Syndrome | Amiodarone | 6.44 | 17391786 15350150 11989578 | |
| MESH:D008133 | Long QT Syndrome | Metoprolol | 6.44 | 19353679 | |
| MESH:D008171 | Lung Diseases | Amiodarone | 5.66 | 12587719 | |
| MESH:D008171 | Lung Diseases | nitrofen | 5.66 | 9859898 9614859 16863852 17245593 | |
| MESH:D017563 | Lung Diseases, Interstitial | Amiodarone | 3.53 | 18516814 | |
| MESH:D055370 | Lung Injury | Lipopolysaccharides | 6.49 | 21114838 | |
| MESH:D055370 | Lung Injury | Oxygen | 6.49 | 18339021 | |
| MESH:D008175 | Lung Neoplasms | therapeutic | 18717826 | ||
| MESH:D008175 | Lung Neoplasms | Arsenic | 13.15 | 17976673 19168569 17306315 | |
| MESH:D008175 | Lung Neoplasms | Azacitidine | 13.15 | 21224363 | |
| MESH:D008175 | Lung Neoplasms | Benzo(a)pyrene | 13.15 | 18816296 20135361 18569708 18520028 20464547 20869020 20064080 6695378 17053015 | |
| MESH:D008175 | Lung Neoplasms | Dexamethasone | 13.15 | 11195469 15824018 | |
| MESH:D008175 | Lung Neoplasms | Doxorubicin | 13.15 | 17418594 6189445 | |
| MESH:D008175 | Lung Neoplasms | Indomethacin | 13.15 | 16537180 11497255 11053908 | |
| MESH:D008175 | Lung Neoplasms | Plant Extracts | 13.15 | 20869020 | |
| MESH:D008175 | Lung Neoplasms | Tetrachlorodibenzodioxin | 13.15 | 19555203 11884234 | |
| MESH:D008175 | Lung Neoplasms | Tetradecanoylphorbol Acetate | 13.15 | 11807781 | |
| MESH:D008175 | Lung Neoplasms | Zidovudine | 13.15 | 18800350 | |
| MESH:D008181 | Lupus Nephritis | Diethylstilbestrol | 4.21 | 15166399 | |
| MESH:D008223 | Lymphoma | Diethylstilbestrol | 5.35 | 15700306 | |
| MESH:D008223 | Lymphoma | Doxorubicin | 5.35 | 16098063 | |
| MESH:D016483 | Lymphoma, AIDS-Related | CHOP protocol | 6.02 | 17177909 | |
| MESH:D016393 | Lymphoma, B-Cell | CHOP protocol | 8.19 | 16322082 | |
| MESH:D016393 | Lymphoma, B-Cell | resveratrol | 8.19 | 17088997 | |
| MESH:D008224 | Lymphoma, Follicular | CHOP protocol | 5.52 | 15000495 | |
| MESH:D016403 | Lymphoma, Large B-Cell, Diffuse | CHOP protocol | 6.02 | 17071492 18186968 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | CHOP protocol | 10.29 | 16283381 16247790 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | Doxorubicin | 10.29 | 17654614 | |
| MESH:D008228 | Lymphoma, Non-Hodgkin | resveratrol | 10.29 | 14749477 | |
| MESH:D016399 | Lymphoma, T-Cell | Doxorubicin | 3.65 | 15621674 | |
| MESH:D052801 | Male Urogenital Diseases | Diethylstilbestrol | 4.56 | 16002989 | |
| MESH:D015674 | Mammary Neoplasms, Animal | resveratrol | 3.33 | 15688416 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Corticosterone | 11.76 | 12807724 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Doxorubicin | 11.76 | 15458769 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Estradiol | 11.76 | 16891317 11408345 11807958 17203775 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | resveratrol | 11.76 | 11606380 8985016 | |
| MESH:D008325 | Mammary Neoplasms, Experimental | Tetradecanoylphorbol Acetate | 11.76 | 8985016 | |
| MESH:D020149 | Manganese Poisoning | Estradiol | 9.86 | 19453300 | |
| MESH:D020149 | Manganese Poisoning | Manganese | 9.86 | 16568477 16551646 19453300 | |
| MESH:D008545 | Melanoma | therapeutic | 18004088 | ||
| MESH:D008545 | Melanoma | Doxorubicin | 6.86 | 16827129 | |
| MESH:D008545 | Melanoma | Glucose | 6.86 | 14993021 | |
| MESH:D008545 | Melanoma | Histamine | 6.86 | 17709802 | |
| MESH:D008545 | Melanoma | resveratrol | 6.86 | 17992120 | |
| MESH:D008545 | Melanoma | trichostatin A | 6.86 | 16505122 | |
| MESH:D008569 | Memory Disorders | Ethanol | 3.31 | 15451040 18411066 | |
| MESH:D008654 | Mesothelioma | Doxorubicin | 2.59 | 17638057 | |
| MESH:D008659 | Metabolic Diseases | phenylmethylpyrazolone | 8.21 | 16301206 | |
| MESH:D008659 | Metabolic Diseases | resveratrol | 8.21 | 17112576 | |
| MESH:D008664 | Metal Metabolism, Inborn Errors | Cyclosporine | 3.84 | 16801185 | |
| MESH:D048629 | Micronuclei, Chromosome-Defective | Zidovudine | 4.89 | 17358032 | |
| MESH:D008881 | Migraine Disorders | Indomethacin | 2.97 | 11903285 | |
| MESH:D020326 | Migraine without Aura | Cyclic AMP | 12.94 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Cyclic GMP | 12.94 | 11304026 | |
| MESH:D020326 | Migraine without Aura | Dinoprostone | 12.94 | 11304026 | |
| MESH:D028361 | Mitochondrial Diseases | Doxorubicin | 3.64 | 15792986 | |
| MESH:D009006 | Monosomy | Azacitidine | 5.13 | 19299654 | |
| MESH:D009062 | Mouth Neoplasms | Benzo(a)pyrene | 6.13 | 16381670 | |
| MESH:D009062 | Mouth Neoplasms | Indomethacin | 6.13 | 12636206 | |
| MESH:D009069 | Movement Disorders | Manganese | 4.14 | 16551646 | |
| MESH:D052016 | Mucositis | Doxorubicin | 3.86 | 17415656 | |
| MESH:D009101 | Multiple Myeloma | Azacitidine | 11.45 | 19549372 18443271 | |
| MESH:D009101 | Multiple Myeloma | Dexamethasone | 11.45 | 16118317 15867202 15744524 | |
| MESH:D009101 | Multiple Myeloma | resveratrol | 11.45 | 17935668 17049120 14749477 16490592 16267019 17164350 | |
| MESH:D009101 | Multiple Myeloma | trichostatin A | 11.45 | 18172295 | |
| MESH:D009102 | Multiple Organ Failure | Zymosan | 4.34 | 10890648 10479408 17724436 15834315 15213630 18160304 15259001 12130978 12879239 15241586 | |
| MESH:D009134 | Muscular Atrophy, Spinal | resveratrol | 3.94 | 17962980 | |
| MESH:D009135 | Muscular Diseases | GW 501516 | 8.03 | 16239165 | |
| MESH:D009135 | Muscular Diseases | pirinixic acid | 8.03 | 16239165 | |
| MESH:D009137 | Muscular Dystrophy, Animal | Gentamicins | 5.32 | 18694830 | |
| MESH:D009164 | Mycobacterium Infections | Indinavir | 4.47 | 21442799 | |
| MESH:D009181 | Mycoses | Amiodarone | 3.95 | 12754197 17974566 | |
| MESH:D009190 | Myelodysplastic Syndromes | Azacitidine | 5.78 | 19805378 18720364 17611569 17596541 | |
| MESH:D009190 | Myelodysplastic Syndromes | Dexamethasone | 5.78 | 9809623 | |
| MESH:D009203 | Myocardial Infarction | Doxorubicin | 12.52 | 19429709 15857846 | |
| MESH:D009203 | Myocardial Infarction | Isoproterenol | 12.52 | 19595682 16697266 16584858 15740881 19172585 17052832 16538859 | |
| MESH:D009203 | Myocardial Infarction | Metoprolol | 12.52 | 18072171 | |
| MESH:D009203 | Myocardial Infarction | pirinixic acid | 12.52 | 19151258 | |
| MESH:D009203 | Myocardial Infarction | resveratrol | 12.52 | 17188708 16456233 17125593 16317513 16525036 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Arsenic | 10.80 | 15371236 | |
| MESH:D017202 | Myocardial Ischemia | resveratrol | 10.80 | 17125593 17015251 | |
| MESH:D017202 | Myocardial Ischemia | Tetrachlorodibenzodioxin | 10.80 | 12213967 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Estradiol | 9.93 | 16810080 | |
| MESH:D015428 | Myocardial Reperfusion Injury | Norepinephrine | 9.93 | 15642760 | |
| MESH:D015428 | Myocardial Reperfusion Injury | pirinixic acid | 9.93 | 16411023 | |
| MESH:D009205 | Myocarditis | resveratrol | 3.83 | 17322642 | |
| MESH:D009362 | Neoplasm Metastasis | therapeutic | 18717826 | ||
| MESH:D009362 | Neoplasm Metastasis | Doxorubicin | 4.46 | 18259882 | |
| MESH:D009362 | Neoplasm Metastasis | Indomethacin | 4.46 | 11239499 11053908 16537180 | |
| MESH:D009369 | Neoplasms | Benzo(a)pyrene | 5.00 | 11141357 | |
| MESH:D009369 | Neoplasms | Diethylstilbestrol | 5.00 | 15313581 | |
| MESH:D009369 | Neoplasms | pirinixic acid | 5.00 | 17405874 | |
| MESH:D009374 | Neoplasms, Experimental | Indomethacin | 6.41 | 10663608 15625704 | |
| MESH:D009374 | Neoplasms, Experimental | resveratrol | 6.41 | 8985016 | |
| MESH:D009389 | Neovascularization, Pathologic | Estradiol | 2.81 | 17289903 | |
| MESH:D009401 | Nephrosis | Doxorubicin | 3.85 | 16899518 16636307 | |
| MESH:D009402 | Nephrosis, Lipoid | Cyclosporine | 3.49 | 17954296 | |
| MESH:D009404 | Nephrotic Syndrome | Cyclosporine | 6.59 | 18481113 19348381 | |
| MESH:D009404 | Nephrotic Syndrome | Doxorubicin | 6.59 | 15640375 16889571 | |
| MESH:D009410 | Nerve Degeneration | Manganese | 3.52 | 16551646 | |
| MESH:D009421 | Nervous System Malformations | Diethylstilbestrol | 11.25 | 11399458 | |
| MESH:D009421 | Nervous System Malformations | Estradiol | 11.25 | 11399458 16427766 | |
| MESH:D009421 | Nervous System Malformations | Tetrachlorodibenzodioxin | 11.25 | 14600291 | |
| MESH:D009436 | Neural Tube Defects | Arsenic | 2.79 | 16620997 | |
| MESH:D019954 | Neurobehavioral Manifestations | Plant Extracts | 4.27 | 17168769 | |
| MESH:D009447 | Neuroblastoma | Doxorubicin | 2.69 | 15555623 | |
| MESH:D019636 | Neurodegenerative Diseases | Indomethacin | 9.84 | 12349958 | |
| MESH:D019636 | Neurodegenerative Diseases | resveratrol | 9.84 | 17652729 | |
| MESH:D019636 | Neurodegenerative Diseases | Tacrolimus | 9.84 | 15081597 | |
| MESH:D020078 | Neurogenic Inflammation | Arsenic | 7.81 | 17056641 | |
| MESH:D020078 | Neurogenic Inflammation | resveratrol | 7.81 | 17929310 | |
| MESH:D009765 | Obesity | pirinixic acid | 3.58 | 20558911 | |
| MESH:D009765 | Obesity | Plant Extracts | 3.58 | 20132043 19056576 | |
| MESH:D007752 | Obstetric Labor, Premature | Indomethacin | 4.22 | 6374098 | |
| MESH:D010003 | Osteoarthritis | Indomethacin | 3.03 | 7009135 | |
| MESH:D010005 | Osteoarthropathy, Secondary Hypertrophic | Dinoprostone | 5.52 | 18500342 | |
| MESH:D015663 | Osteoporosis, Postmenopausal | resveratrol | 3.39 | 17513867 | |
| MESH:D012516 | Osteosarcoma | Doxorubicin | 3.33 | 15930896 | |
| MESH:D010051 | Ovarian Neoplasms | Arsenic | 10.50 | 17306315 | |
| MESH:D010051 | Ovarian Neoplasms | Estradiol | 10.50 | 19401270 | |
| MESH:D010051 | Ovarian Neoplasms | Mifepristone | 10.50 | 16525653 | |
| MESH:D010051 | Ovarian Neoplasms | trichostatin A | 10.50 | 19331143 | |
| MESH:D010051 | Ovarian Neoplasms | U 0126 | 10.50 | 16211241 | |
| MESH:D010146 | Pain | therapeutic | 13679232 | ||
| MESH:D010146 | Pain | Indomethacin | 2.73 | 17627676 13679232 17440234 3291741 | |
| MESH:D010149 | Pain, Postoperative | Indomethacin | 3.74 | 12538197 18702446 | |
| MESH:D010190 | Pancreatic Neoplasms | Ethanol | 6.19 | 12384795 | |
| MESH:D010190 | Pancreatic Neoplasms | Tetradecanoylphorbol Acetate | 6.19 | 15976015 | |
| MESH:D010190 | Pancreatic Neoplasms | trichostatin A | 6.19 | 19294695 | |
| MESH:D010195 | Pancreatitis | Cimetidine | 9.52 | 10484002 | |
| MESH:D010195 | Pancreatitis | Indomethacin | 9.52 | 17883296 15028970 | |
| MESH:D010195 | Pancreatitis | phenylmethylpyrazolone | 9.52 | 20035747 | |
| MESH:D010212 | Papilloma | Hydrogen Peroxide | 10.55 | 12065085 | |
| MESH:D010212 | Papilloma | Plant Extracts | 10.55 | 16517061 15173996 | |
| MESH:D010212 | Papilloma | Tetradecanoylphorbol Acetate | 10.55 | 12065085 8330346 18404319 18922899 | |
| MESH:D010257 | Paraneoplastic Syndromes | Indomethacin | 4.77 | 16537180 | |
| MESH:D010300 | Parkinson Disease | Manganese | 2.95 | 11181820 | |
| MESH:D020734 | Parkinsonian Disorders | Indomethacin | 6.77 | 12349958 | |
| MESH:D020734 | Parkinsonian Disorders | Manganese | 6.77 | 16140633 | |
| MESH:D051302 | Paroxysmal Hemicrania | Indomethacin | 4.77 | 11903285 | |
| MESH:D010382 | Peliosis Hepatis | Tetrachlorodibenzodioxin | 3.30 | 12520081 | |
| MESH:D010437 | Peptic Ulcer | Indomethacin | 4.22 | 11148446 | |
| MESH:D010518 | Periodontitis | Indomethacin | 3.97 | 17225004 | |
| MESH:D010523 | Peripheral Nervous System Diseases | Arsenic | 3.29 | 16093927 | |
| MESH:D016491 | Peripheral Vascular Diseases | Arsenic | 4.06 | 15371236 6392382 16905509 | |
| MESH:D010538 | Peritonitis | Zymosan | 3.98 | 18557954 11985352 15259001 18977430 19641140 18760300 19088179 14761945 17826846 17371808 15979727 | |
| MESH:D003557 | Phyllodes Tumor | Doxorubicin | 4.21 | 17983394 | |
| MESH:D010900 | Pituitary Diseases | Diethylstilbestrol | 4.22 | 14722030 | |
| MESH:D010911 | Pituitary Neoplasms | Diethylstilbestrol | 3.76 | 16977796 15687265 | |
| MESH:D010997 | Pleural Neoplasms | Doxorubicin | 4.21 | 17638057 | |
| MESH:D011014 | Pneumonia | Lipopolysaccharides | 3.63 | 11605937 12224865 | |
| MESH:D011041 | Poisoning | N(6)-cyclopentyladenosine | 5.06 | 16105447 | |
| MESH:D017119 | Porphyria Cutanea Tarda | Tetrachlorodibenzodioxin | 2.67 | 18163543 | |
| MESH:D011230 | Precancerous Conditions | Cyclosporine | 2.41 | 12371664 | |
| MESH:D054198 | Precursor Cell Lymphoblastic Leukemia-Lymphoma | Dexamethasone | 2.93 | 21297632 | |
| MESH:D047928 | Premature Birth | Indomethacin | 4.21 | 17000239 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Diethylstilbestrol | 10.98 | 17184923 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | resveratrol | 10.98 | 16679765 | |
| MESH:D011297 | Prenatal Exposure Delayed Effects | Tetrachlorodibenzodioxin | 10.98 | 11118676 11896295 11399792 11222880 | |
| MESH:D055728 | Primary Myelofibrosis | trichostatin A | 4.34 | 17616702 | |
| MESH:D019048 | Prostatic Intraepithelial Neoplasia | Estradiol | 3.03 | 20887781 | |
| MESH:D011471 | Prostatic Neoplasms | therapeutic | 18225537 | ||
| MESH:D011471 | Prostatic Neoplasms | Arsenic | 2.34 | 16140617 | |
| MESH:D011471 | Prostatic Neoplasms | Azacitidine | 2.34 | 18324645 | |
| MESH:D011471 | Prostatic Neoplasms | Benzo(a)pyrene | 2.34 | 17292933 | |
| MESH:D011471 | Prostatic Neoplasms | Diethylstilbestrol | 2.34 | 15046698 15846301 17136230 | |
| MESH:D011471 | Prostatic Neoplasms | Doxorubicin | 2.34 | 16729912 15749863 18437689 16868541 16888761 15897917 | |
| MESH:D011471 | Prostatic Neoplasms | Estradiol | 2.34 | 16740699 | |
| MESH:D011471 | Prostatic Neoplasms | Plant Extracts | 2.34 | 14666653 17804756 | |
| MESH:D011471 | Prostatic Neoplasms | resveratrol | 2.34 | 17675339 17636462 15767336 17804756 17718901 16731767 | |
| MESH:D011471 | Prostatic Neoplasms | trichostatin A | 2.34 | 18798265 19789329 | |
| MESH:D011507 | Proteinuria | Arsenic | 10.66 | 21343184 | |
| MESH:D011507 | Proteinuria | Gentamicins | 10.66 | 15033597 | |
| MESH:D011507 | Proteinuria | Indomethacin | 10.66 | 11849393 | |
| MESH:D011565 | Psoriasis | Cyclosporine | 1.80 | 16882103 | |
| MESH:D011654 | Pulmonary Edema | Isoproterenol | 4.31 | 10903255 | |
| MESH:D011658 | Pulmonary Fibrosis | Amiodarone | 2.41 | 12832656 12490602 11597910 | |
| MESH:D012021 | Reflex, Abnormal | Pentobarbital | 5.09 | 10930210 | |
| MESH:D051437 | Renal Insufficiency | Doxorubicin | 7.58 | 17922066 | |
| MESH:D051437 | Renal Insufficiency | Gentamicins | 7.58 | 17132701 15728788 | |
| MESH:D051436 | Renal Insufficiency, Chronic | resveratrol | 4.63 | 16325855 | |
| MESH:D015427 | Reperfusion Injury | phenylmethylpyrazolone | 7.81 | 16753835 16041266 14654979 15948865 15086910 15629865 | |
| MESH:D015427 | Reperfusion Injury | pirinixic acid | 7.81 | 19058328 | |
| MESH:D015427 | Reperfusion Injury | resveratrol | 7.81 | 17520802 16317513 15827377 16314181 17058453 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Dexamethasone | 6.61 | 11700416 18379247 | |
| MESH:D012128 | Respiratory Distress Syndrome, Adult | Oxygen | 6.61 | 17627322 18339021 | |
| MESH:D012130 | Respiratory Hypersensitivity | Lipopolysaccharides | 3.05 | 10835634 | |
| MESH:D015619 | Respiratory System Abnormalities | Tetrachlorodibenzodioxin | 2.94 | 18990726 | |
| MESH:D012173 | Retinitis | Gentamicins | 5.32 | 18644591 | |
| MESH:D012206 | Rhabdomyolysis | Lamivudine | 4.60 | 9296927 | |
| MESH:D012220 | Rhinitis | Histamine | 4.16 | 12689652 | |
| MESH:D012509 | Sarcoma | Doxorubicin | 3.16 | 16767912 18313854 17203757 17710206 15625365 15675481 | |
| MESH:D012512 | Sarcoma, Ewing's | Doxorubicin | 3.35 | 16326096 14601052 | |
| MESH:D012514 | Sarcoma, Kaposi | Doxorubicin | 3.86 | 17846226 | |
| MESH:D012640 | Seizures | Clonidine | 6.36 | 10087439 | |
| MESH:D012640 | Seizures | Ethanol | 6.36 | 9754883 | |
| MESH:D012640 | Seizures | Pentobarbital | 6.36 | 9754883 10087439 | |
| MESH:D018805 | Sepsis | Zymosan | 3.86 | 11441115 | |
| OMIM:609620 | SHORT QT SYNDROME 1 | Amiodarone | 4.15 | 18724381 | |
| MESH:D012852 | Sinusitis | Phenylephrine | 3.78 | 7327846 | |
| MESH:D012859 | Sjogren's Syndrome | CHOP protocol | 6.22 | 16322082 | |
| MESH:D012871 | Skin Diseases | Arsenic | 2.42 | 17938729 16702368 17050553 16353154 17453740 16759981 6392382 19834688 18709164 15952646 17548696 | |
| MESH:D012878 | Skin Neoplasms | therapeutic | 18004088 | ||
| MESH:D012878 | Skin Neoplasms | Arsenic | 26.08 | 17976673 16251483 17029826 19538983 17050553 15504454 | |
| MESH:D012878 | Skin Neoplasms | Benzo(a)pyrene | 26.08 | 19755658 10029692 | |
| MESH:D012878 | Skin Neoplasms | Doxorubicin | 26.08 | 15692506 | |
| MESH:D012878 | Skin Neoplasms | Glucose | 26.08 | 14993021 | |
| MESH:D012878 | Skin Neoplasms | Hydrogen Peroxide | 26.08 | 12065085 | |
| MESH:D012878 | Skin Neoplasms | Plant Extracts | 26.08 | 15173996 16517061 | |
| MESH:D012878 | Skin Neoplasms | resveratrol | 26.08 | 15837718 8985016 | |
| MESH:D012878 | Skin Neoplasms | Tetrachlorodibenzodioxin | 26.08 | 16192470 | |
| MESH:D012878 | Skin Neoplasms | Tetradecanoylphorbol Acetate | 26.08 | 8330346 12065085 18404319 8985016 11807781 | |
| MESH:D012893 | Sleep Disorders | Caffeine | 4.39 | 19395429 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Caffeine | 7.79 | 17225163 | |
| MESH:D007319 | Sleep Initiation and Maintenance Disorders | Clonidine | 7.79 | 18280681 | |
| MESH:D012983 | Soft Tissue Neoplasms | Doxorubicin | 3.65 | 17203757 16767912 15625365 | |
| MESH:D013088 | Spermatocele | Diethylstilbestrol | 3.77 | 16709447 16002989 | |
| MESH:D013272 | Stomach Diseases | Dexamethasone | 11.98 | 15472012 | |
| MESH:D013272 | Stomach Diseases | Indomethacin | 11.98 | 18545984 10486359 15038085 10215738 17638125 15472012 16280098 17160473 16113693 10192188 18209964 16184426 17207306 | |
| MESH:D013272 | Stomach Diseases | sildenafil | 11.98 | 16113693 | |
| MESH:D013274 | Stomach Neoplasms | Benzo(a)pyrene | 3.46 | 20155912 2093021 | |
| MESH:D013274 | Stomach Neoplasms | Ethanol | 3.46 | 18456281 | |
| MESH:D013274 | Stomach Neoplasms | Indomethacin | 3.46 | 15609394 | |
| MESH:D013274 | Stomach Neoplasms | Zidovudine | 3.46 | 17696246 | |
| MESH:D013276 | Stomach Ulcer | Amiodarone | 13.77 | 18087811 | |
| MESH:D013276 | Stomach Ulcer | Dexamethasone | 13.77 | 15138204 | |
| MESH:D013276 | Stomach Ulcer | Ethanol | 13.77 | 9562338 17918041 9211565 16755016 17189318 11906479 | |
| MESH:D013276 | Stomach Ulcer | Indomethacin | 13.77 | 10750652 11906479 10423059 18209962 16150113 17654042 17627676 11595431 16252198 18193104 18543354 12787963 17918041 18299717 1323529 11729361 12077510 18726076 16397915 17977527 12500499 14567935 17135157 12467913 15138204 11145282 18431645 18181030 16755016 16631530 15104355 17657623 10878458 12498302 17895592 16934674 15255614 16169175 11523592 11595415 18237397 18087811 | |
| MESH:D013276 | Stomach Ulcer | Plant Extracts | 13.77 | 15255614 17135157 12787963 18237397 18193104 | |
| OMIM:601367 | STROKE, ISCHEMIC | resveratrol | 3.64 | 16321402 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Ethanol | 7.49 | 9754883 | |
| MESH:D013375 | Substance Withdrawal Syndrome | Pentobarbital | 7.49 | 11529278 9754883 | |
| MESH:D013398 | Sudden Infant Death | Oxygen | 4.61 | 12563064 | |
| MESH:D013610 | Tachycardia | Amiodarone | 8.15 | 11238279 | |
| MESH:D013610 | Tachycardia | Norepinephrine | 8.15 | 3261545 | |
| MESH:D017180 | Tachycardia, Ventricular | Amiodarone | 3.30 | 19225199 | |
| MESH:D013705 | Temporomandibular Joint Disorders | Plant Extracts | 4.53 | 17997062 | |
| MESH:D013921 | Thrombocytopenia | Lipopolysaccharides | 3.34 | 15821434 | |
| MESH:D013959 | Thyroid Diseases | Amiodarone | 8.91 | 19731979 | |
| MESH:D013959 | Thyroid Diseases | Tetrachlorodibenzodioxin | 8.91 | 12697716 | |
| MESH:D013964 | Thyroid Neoplasms | 2-(2-chloro-4-iodophenylamino)-N-cyclopropylmethoxy-3,4-difluorobenzamide | 8.04 | 16940797 | |
| MESH:D013964 | Thyroid Neoplasms | Doxorubicin | 8.04 | 17909728 16010429 | |
| MESH:D013964 | Thyroid Neoplasms | Indomethacin | 8.04 | 11352223 18791128 14736730 | |
| MESH:D013971 | Thyrotoxicosis | Amiodarone | 3.94 | 19584973 18020914 | |
| MESH:D013978 | Tibial Fractures | Estradiol | 3.74 | 19048282 | |
| MESH:D014062 | Tongue Neoplasms | resveratrol | 3.38 | 16227395 | |
| MESH:D016171 | Torsades de Pointes | Amiodarone | 7.95 | 17467628 11989578 | |
| MESH:D016171 | Torsades de Pointes | Metoprolol | 7.95 | 19353679 | |
| MESH:D014456 | Ulcer | Indomethacin | 3.96 | 17380554 10574470 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Arsenic | 7.94 | 11144890 17976673 17306315 19322015 15987713 18640142 19429237 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Benzo(a)pyrene | 7.94 | 17053015 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Diethylstilbestrol | 7.94 | 16452187 16712894 17306315 | |
| MESH:D001749 | Urinary Bladder Neoplasms | Doxorubicin | 7.94 | 17653716 | |
| MESH:D014581 | Urticaria | Histamine | 4.19 | 18298128 | |
| MESH:D002583 | Uterine Cervical Neoplasms | Diethylstilbestrol | 6.90 | 16175088 | |
| MESH:D002583 | Uterine Cervical Neoplasms | resveratrol | 6.90 | 17473185 | |
| MESH:D014591 | Uterine Diseases | Diethylstilbestrol | 4.22 | 14652134 | |
| MESH:D014594 | Uterine Neoplasms | Diethylstilbestrol | 6.84 | 15809267 16690809 | |
| MESH:D014594 | Uterine Neoplasms | resveratrol | 6.84 | 17044934 | |
| MESH:D014605 | Uveitis | Cyclosporine | 14.85 | 1336536 | |
| MESH:D014605 | Uveitis | Dexamethasone | 14.85 | 1336536 | |
| MESH:D014605 | Uveitis | Zymosan | 14.85 | 11006244 | |
| MESH:D014625 | Vaginal Neoplasms | Diethylstilbestrol | 8.11 | 16002989 16513791 | |
| MESH:D014625 | Vaginal Neoplasms | Zidovudine | 8.11 | 12579204 | |
| MESH:D014652 | Vascular Diseases | Arsenic | 3.80 | 17056641 | |
| MESH:D054079 | Vascular Malformations | Tetrachlorodibenzodioxin | 3.64 | 12125929 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Dietary Sucrose | 22.47 | 18551017 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Doxorubicin | 22.47 | 16364871 17334414 17638931 17678736 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Isoproterenol | 22.47 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | Plant Extracts | 22.47 | 18097624 | |
| MESH:D018487 | Ventricular Dysfunction, Left | resveratrol | 22.47 | 17488730 | |
| MESH:D020257 | Ventricular Remodeling | Isoproterenol | 9.77 | 18097624 | |
| MESH:D020257 | Ventricular Remodeling | Plant Extracts | 9.77 | 18097624 | |
| MESH:D015837 | Vestibular Diseases | Gentamicins | 4.62 | 18776599 | |
| MESH:D014839 | Vomiting | Indomethacin | 3.80 | 11897121 | |
| MESH:D019282 | Wasting Syndrome | Tetrachlorodibenzodioxin | 3.30 | 15886252 | |
| MESH:D014947 | Wounds and Injuries | lysophosphatidic acid | 6.78 | 15541073 | |
| MESH:D014947 | Wounds and Injuries | Plant Extracts | 6.78 | 19894650 20213670 | |
| MESH:D014985 | Xerophthalmia | Cyclosporine | 3.49 | 17120751 |
| Pathway ID | Pathway Name |
|---|---|
| KEGG:04270 | Vascular smooth muscle contraction |
| No data |
| Releated disease ID | Related disease Name |
|---|---|
| PA443450 | Asthma |
| PA443421 | Arrhythmias, Cardiac |
| PA159018367 | Brugada syndrome |
| PA443633 | Cardiomyopathy, Hypertrophic |
| PA443796 | Coronary Artery Disease |
| PA446379 | Death, Sudden, Cardiac |
| PA444368 | Heart Diseases |
| PA444807 | Long QT Syndrome |
| PA445769 | Sudden Infant Death |
| PA445848 | Thromboembolism |
| PA446294 | Torsades de Pointes |
| PA446028 | Ventricular Fibrillation |
| PA443459 | Atrial Fibrillation |
| PA443635 | Cardiovascular Diseases |
| PA447054 | Stroke |
| PA443797 | Coronary Disease |
| PA443842 | Death |
| PA444370 | Heart Failure |
| PA444552 | Hypertension |
| PA445019 | Myocardial Infarction |
| Releated drug ID | Related drug Name |
|---|---|
| PA449167 | cyclosporine |
| PA451578 | tacrolimus |
| PA164712547 | Beta blocking agents, selective |
| PA451906 | warfarin |
| PA448547 | beclomethasone |
| PA164754818 | betamethasone |
| PA448681 | budesonide |
| PA164781399 | ciclesonide |
| PA164776996 | desonide |
| PA449247 | dexamethasone |
| PA449661 | flunisolide |
| PA449686 | fluticasone propionate |
| PA452347 | glucocorticoids |
| PA449905 | hydrocortisone |
| PA448478 | l-arginine |
| PA164747225 | l-citrulline |
| PA450466 | methylprednisolone |
| PA450541 | mometasone |
| PA450635 | nitric oxide |
| PA164777035 | paramethasone |
| PA451096 | prednisolone |
| PA451100 | prednisone |
| PA164752251 | rimexolone |
| PA451749 | triamcinolone |
| PA448388 | amlodipine |
| PA448970 | chlorthalidone |
| PA449407 | doxazosin |
| PA450242 | lisinopril |
Drug Bank